1
|
Lamar M, Arfanakis K, Evia A, Makkinejad N, Capuano AW, Kim N, Leurgans SE, Fleischman DA, Duke Han S, Poole V, Barnes LL. Changes in an in-vivo classifier of ARTerioloSclerosis (ARTS) with simultaneous change in cognition for older African Americans. Neurobiol Aging 2024; 134:21-27. [PMID: 37979249 PMCID: PMC10845033 DOI: 10.1016/j.neurobiolaging.2023.11.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Revised: 10/30/2023] [Accepted: 11/06/2023] [Indexed: 11/20/2023]
Abstract
At autopsy, African American decedents often have mixed Alzheimer's and cerebrovascular brain pathologies including arteriolosclerosis. We applied a novel in-vivo classifier of ARTerioloSclerosis (ARTS) in 167 older African Americans (∼75y of age) with > 2 biennial 3 T MRI scans and > 3 years of associated cognitive follow-up to determine if ARTS scores (higher score=higher likelihood of arteriolosclerosis) changed over time and if this change associated with changes in cognition in the same individuals. Mixed effects regression models tested whether ARTS scores increased over time, while simultaneous mixed effects regression models estimated the simultaneous rates of change in both ARTS and cognition and the correlation of these changes. ARTS scores increased over time (estimate=0.030, SE=0.002, p < 0.0001). Faster increases in ARTS were associated with faster rates of global cognitive decline (r = -0.447, p = 0.006) and domain-specific cognitive functions. Applying an in-vivo marker of arteriolosclerosis in an African American cohort revealed that the likelihood of arteriolosclerosis increases over time, and participants whose ARTS scores increased more rapidly tended to have faster than average rates of cognitive decline.
Collapse
Affiliation(s)
- Melissa Lamar
- Rush Alzheimer's Disease Center, USA; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA.
| | - Konstantinos Arfanakis
- Rush Alzheimer's Disease Center, USA; Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA; Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, IL, USA
| | | | - Nazanin Makkinejad
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA
| | - Ana W Capuano
- Rush Alzheimer's Disease Center, USA; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Namhee Kim
- Rush Alzheimer's Disease Center, USA; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Sue E Leurgans
- Rush Alzheimer's Disease Center, USA; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Debra A Fleischman
- Rush Alzheimer's Disease Center, USA; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - S Duke Han
- Rush Alzheimer's Disease Center, USA; Department of Family Medicine, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA
| | - Victoria Poole
- Rush Alzheimer's Disease Center, USA; Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, USA
| | - Lisa L Barnes
- Rush Alzheimer's Disease Center, USA; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| |
Collapse
|
2
|
Lamar M, Arfanakis K, Yu L, Kapasi A, Duke Han S, Fleischman DA, Bennett DA, Boyle P. The Relationship of MRI-Derived Alzheimer's and Cerebrovascular-Related Signatures With Level of and Change in Health and Financial Literacy. Am J Geriatr Psychiatry 2023; 31:1129-1139. [PMID: 37541932 PMCID: PMC10800641 DOI: 10.1016/j.jagp.2023.07.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/11/2023] [Revised: 07/13/2023] [Accepted: 07/14/2023] [Indexed: 08/06/2023]
Abstract
OBJECTIVE The cortical thickness "signature" of Alzheimer's disease (AD-CT) and white matter hyperintensity (WMH) burden have each been associated with cognitive aging and incident AD and related dementias. Less is known about how these structural neuroimaging markers associate with other critical behaviors. We investigated associations of AD-CT and WMH volumes with a composite index of health and financial literacy given that the ability to access, understand, and utilize health and financial information significantly influences older adults' health outcomes. DESIGN, SETTING, PARTICIPANTS Participants were 303 adults without dementia (age∼80 years; 74% women) from the Rush Memory and Aging Project. MEASUREMENTS Baseline 3T MRI T1-weighted structural and T2-weighted FLAIR data were used to assess AD-CT and WMH volumes, respectively. Literacy was measured using questions designed to assess comprehension of health and financial information and concepts, yielding a total literacy score. Multivariable linear mixed effects regression models determined the relationship of each neuroimaging marker, first separately and then combined, with the level of and change in literacy. RESULTS Reduced AD-CT and higher WMH at baseline were each associated with lower levels of literacy; only AD-CT was associated with the rate of decline in literacy over time. The association of AD-CT with change in literacy persisted when both neuroimaging markers were included in the same model. CONCLUSIONS The cortical thickness signature of AD predicts changes in health and financial literacy in nondemented older adults suggesting that the multidimensional construct of health and financial literacy relies on specific brain networks implicated in AD.
Collapse
Affiliation(s)
- Melissa Lamar
- Rush Alzheimer's Disease Center (ML, KA, LY, AK, SDH, DAF, DAB, PB), Rush University Medical Center, Chicago, IL; Department of Psychiatry and Behavioral Sciences (ML, DAF, PB), Rush University Medical Center, Chicago, IL.
| | - Konstantinos Arfanakis
- Rush Alzheimer's Disease Center (ML, KA, LY, AK, SDH, DAF, DAB, PB), Rush University Medical Center, Chicago, IL; Department of Diagnostic Radiology and Nuclear Medicine (KA, AK), Rush University Medical Center, Chicago, IL; Department of Biomedical Engineering (KA), Illinois Institute of Technology, Chicago, IL
| | - Lei Yu
- Rush Alzheimer's Disease Center (ML, KA, LY, AK, SDH, DAF, DAB, PB), Rush University Medical Center, Chicago, IL; Department of Neurological Sciences (LY, DAF, DAB), Rush University Medical Center, Chicago, IL
| | - Alifiya Kapasi
- Rush Alzheimer's Disease Center (ML, KA, LY, AK, SDH, DAF, DAB, PB), Rush University Medical Center, Chicago, IL; Department of Diagnostic Radiology and Nuclear Medicine (KA, AK), Rush University Medical Center, Chicago, IL
| | - S Duke Han
- Rush Alzheimer's Disease Center (ML, KA, LY, AK, SDH, DAF, DAB, PB), Rush University Medical Center, Chicago, IL; Department of Family Medicine (SDH), Keck School of Medicine of University of Southern California, Los Angeles, CA
| | - Debra A Fleischman
- Rush Alzheimer's Disease Center (ML, KA, LY, AK, SDH, DAF, DAB, PB), Rush University Medical Center, Chicago, IL; Department of Psychiatry and Behavioral Sciences (ML, DAF, PB), Rush University Medical Center, Chicago, IL; Department of Neurological Sciences (LY, DAF, DAB), Rush University Medical Center, Chicago, IL
| | - David A Bennett
- Rush Alzheimer's Disease Center (ML, KA, LY, AK, SDH, DAF, DAB, PB), Rush University Medical Center, Chicago, IL; Department of Neurological Sciences (LY, DAF, DAB), Rush University Medical Center, Chicago, IL
| | - Patricia Boyle
- Rush Alzheimer's Disease Center (ML, KA, LY, AK, SDH, DAF, DAB, PB), Rush University Medical Center, Chicago, IL; Department of Psychiatry and Behavioral Sciences (ML, DAF, PB), Rush University Medical Center, Chicago, IL
| |
Collapse
|
3
|
Fleischman DA, Arfanakis K, Leurgans SE, Zhang S, Lamar M, Han SD, Poole VN, Kim N, Bennett DA, Barnes LL. Late-life depressive symptoms and white matter structural integrity within older Black adults. Front Aging Neurosci 2023; 15:1138568. [PMID: 37205056 PMCID: PMC10186351 DOI: 10.3389/fnagi.2023.1138568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2023] [Accepted: 04/12/2023] [Indexed: 05/21/2023] Open
Abstract
Introduction Older Black adults experience a high burden of depressive symptoms and cerebrovascular disease but the specific neurobiological substrates underlying the association between late-life depressive symptoms and brain integrity are understudied, particularly in within-group designs. Methods Using the Center for Epidemiologic Studies Depression Scale and diffusion-tensor imaging, within-Black variation in the association between late-life depressive symptoms and white matter structural integrity was examined in 297 older Black participants without dementia that were enrolled across three epidemiological studies of aging and dementia. Linear regression models were used to test associations with DTI metrics (fractional anisotropy, trace of the diffusion tensor) as the outcomes and depressive symptoms as the predictor, while adjusting for age, sex, education, scanner, serotonin-reuptake inhibitor use, total volume of white-matter hyperintensities normalized by intracranial volume, and presence of white-matter hyperintensities at the voxel level. Results Higher level of self-reported late-life depressive symptoms was associated with greater diffusion-tensor trace (reduced white matter integrity) in connections between commissural pathways and contralateral prefrontal regions (superior and middle frontal/dorsolateral prefrontal cortex), association pathways connecting dorsolateral prefrontal cortex with insular, striatal and thalamic regions, and association pathways connecting the parietal, temporal and occipital lobes and the thalamus. Discussion This study demonstrated a discernable pattern of compromised white matter structural integrity underlying late-life depressive symptoms within older Black adults.
Collapse
Affiliation(s)
- Debra A. Fleischman
- Rush Alzheimer’s Disease Center, Chicago, IL, United States
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, United States
- Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, United States
| | - Konstantinos Arfanakis
- Rush Alzheimer’s Disease Center, Chicago, IL, United States
- Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, IL, United States
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, United States
| | - Sue E. Leurgans
- Rush Alzheimer’s Disease Center, Chicago, IL, United States
- Department of Preventive Medicine, Rush University Medical Center, Chicago IL, United States
| | - Shengwei Zhang
- Rush Alzheimer’s Disease Center, Chicago, IL, United States
| | - Melissa Lamar
- Rush Alzheimer’s Disease Center, Chicago, IL, United States
- Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, United States
| | - S. Duke Han
- Rush Alzheimer’s Disease Center, Chicago, IL, United States
- Department of Family Medicine and Neurology, Keck School of Medicine, Los Angeles, CA, United States
- Department of Psychology, University of Southern California, Los Angeles, CA, United States
- School of Gerontology, University of Southern California, Los Angeles, CA, United States
| | - Victoria N. Poole
- Rush Alzheimer’s Disease Center, Chicago, IL, United States
- Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, United States
| | - Namhee Kim
- Rush Alzheimer’s Disease Center, Chicago, IL, United States
| | | | - Lisa L. Barnes
- Rush Alzheimer’s Disease Center, Chicago, IL, United States
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, United States
- Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, United States
| |
Collapse
|
4
|
Lamar M, Glover CM, Capuano AW, Wilson RS, Fleischman DA, Bennett DA, Marquez DX. Stability and change in acculturation-related characteristics in older Latinos: Implications for culturally compatible ADRD research. Alzheimers Dement (N Y) 2023; 9:e12380. [PMID: 37051589 PMCID: PMC10083703 DOI: 10.1002/trc2.12380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/30/2022] [Revised: 02/16/2023] [Accepted: 03/01/2023] [Indexed: 04/14/2023]
Abstract
Introduction Acculturation-related characteristics, that is, factors directly connected to culture and familial relationships, are associated with engaged research participation within Latino communities. Despite this, little empirical data exists on whether acculturation changes over time in older Latinos, which has potential implications for Alzheimer's disease and related dementias (ADRD) research study design including longer duration clinical trial implementation. Methods Self-identified Latinos (n = 222; mean age = 71, 76% female) participating in one of three ongoing longitudinal community-based cohort studies of aging who reported their nativity outside of the United States/District of Columbia (US/DC) contributed, on average, 4.0 ± 1.2 years of annually collected data. This included acculturation-related characteristics of total, language-, and social-based scores from the Short Acculturation Scale for Hispanics (SASH) and total and domain-specific scores from an abbreviated Sabogal Familism questionnaire. We used ordinal mixed effects models and linear mixed effects models (as appropriate) to assess change in acculturation metrics after adjusting for age, sex, education, income, and duration of time in the US/DC. Results Although none of the SASH metrics changed over time (P-values ≥ 0.25), all Familism metrics declined over time (P-values ≤ 0.044). Additionally, select participant-based characteristics including years of education were significantly (and differentially) associated with level of, but not change in, acculturation-related outcomes. Discussion Results suggest that specific acculturation-related factors (i.e., familism) change over time in older Latinos, and participant-based characteristics associated with baseline levels of (but not change in) acculturation more generally. Thus, acculturation-related characteristics are not all static, trait-like qualities but rather a multi-faceted, and at times evolving, construct. Considering this dynamic phenotyping is important when contextualizing older Latinos' lived experience, and when designing, adapting, and conducting ADRD clinical trials and other health-related interventions.
Collapse
Affiliation(s)
- Melissa Lamar
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Psychiatry and Behavioral SciencesRush University Medical CenterChicagoIllinoisUSA
| | - Crystal M. Glover
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Psychiatry and Behavioral SciencesRush University Medical CenterChicagoIllinoisUSA
- Department of Neurological SciencesRush University Medical CenterChicagoIllinoisUSA
| | - Ana W. Capuano
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Neurological SciencesRush University Medical CenterChicagoIllinoisUSA
| | - Robert S. Wilson
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Psychiatry and Behavioral SciencesRush University Medical CenterChicagoIllinoisUSA
| | - Debra A. Fleischman
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Psychiatry and Behavioral SciencesRush University Medical CenterChicagoIllinoisUSA
- Department of Neurological SciencesRush University Medical CenterChicagoIllinoisUSA
| | - David A. Bennett
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Neurological SciencesRush University Medical CenterChicagoIllinoisUSA
| | - David X. Marquez
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Kinesiology and NutritionUniversity of Illinois ChicagoChicagoIllinoisUSA
| |
Collapse
|
5
|
Lamar M, Estrella ML, Capuano AW, Leurgans S, Fleischman DA, Barnes LL, Lange‐Maia BS, Bennett DA, Marquez DX. A Longitudinal Study of Acculturation in Context and Cardiovascular Health and Their Effects on Cognition Among Older Latino Adults. J Am Heart Assoc 2023; 12:e027620. [PMID: 36926993 PMCID: PMC10111521 DOI: 10.1161/jaha.122.027620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/25/2022] [Accepted: 01/23/2023] [Indexed: 03/18/2023]
Abstract
Background We previously outlined the importance of considering acculturation within the context of older Latino adults' lived experience (ie, acculturation in context) to better capture contributors to cognitive aging. We now examine this conceptual framework as related to level of and change in cardiovascular health, and whether cardiovascular health modifies previously documented associations of acculturation in context with cognition. Methods and Results Acculturation in context data from 192 Latino participants without dementia at baseline (age ~70 years) were compiled into 3 separate composite scores: acculturation-related (nativity, language-, and social-based preferences), contextually related socioenvironmental (experiences of discrimination, social isolation, social networks), and familism-related (Latino-centric family ethos). A modified American Heart Association's Life's Simple 7 (mLS7; ie, smoking, physical activity, body mass index, blood pressure, total cholesterol, blood glucose) was used to measure cardiovascular health. Mixed effects regressions simultaneously tested the association of all 3 composite scores with total mLS7 adjusting for confounders. Separate models tested whether mLS7 modified associations of the 3 composite scores and cognition. The contextually related socioenvironmental composite score reflecting higher discrimination, higher social isolation, and smaller social networks (estimate=0.22, SE=0.10, P=0.02) and the familism score (estimate=0.16, SE=0.07, P=0.02) both significantly associated with change in total mLS7. The acculturation-related composite was not significantly associated with change in mLS7. No composite was significantly associated with level of mLS7. Total mLS7, however, significantly modified associations between the acculturation-related composite and change in working memory (estimate=-0.02, SE=0.01, P=0.043). Conclusions Acculturation within the context of older Latino adults' lived experience is important for maintaining cardiovascular health, relationships that also affect domain-specific cognitive decline.
Collapse
Affiliation(s)
- Melissa Lamar
- Rush Alzheimer’s Disease CenterRush University Medical CenterChicagoIL
- Department of Psychiatry and Behavioral SciencesRush University Medical CenterChicagoIL
| | - Mayra L. Estrella
- Department of Epidemiology, Human Genetics and Environmental SciencesUniversity of Texas Health Science Center at Houston School of Public HealthBrownsvilleTX
| | - Ana W. Capuano
- Rush Alzheimer’s Disease CenterRush University Medical CenterChicagoIL
- Department of Neurological SciencesRush University Medical CenterChicagoIL
| | - Sue Leurgans
- Rush Alzheimer’s Disease CenterRush University Medical CenterChicagoIL
- Department of Neurological SciencesRush University Medical CenterChicagoIL
| | - Debra A. Fleischman
- Rush Alzheimer’s Disease CenterRush University Medical CenterChicagoIL
- Department of Psychiatry and Behavioral SciencesRush University Medical CenterChicagoIL
- Department of Neurological SciencesRush University Medical CenterChicagoIL
| | - Lisa L. Barnes
- Rush Alzheimer’s Disease CenterRush University Medical CenterChicagoIL
- Department of Psychiatry and Behavioral SciencesRush University Medical CenterChicagoIL
- Department of Neurological SciencesRush University Medical CenterChicagoIL
| | - Brittney S. Lange‐Maia
- Rush Alzheimer’s Disease CenterRush University Medical CenterChicagoIL
- Department of Preventive MedicineRush University Medical CenterChicagoIL
| | - David A. Bennett
- Rush Alzheimer’s Disease CenterRush University Medical CenterChicagoIL
- Department of Neurological SciencesRush University Medical CenterChicagoIL
| | - David X. Marquez
- Rush Alzheimer’s Disease CenterRush University Medical CenterChicagoIL
- Department of Kinesiology and NutritionUniversity of Illinois ChicagoChicagoIL
| |
Collapse
|
6
|
Fleischman DA, Arfanakis K, Zhang S, Leurgans SE, Barnes LL, Bennett DA, Marquez DX, Lamar M. Acculturation in Context and Brain Health in Older Latino Adults: A Diffusion Tensor Imaging Study. J Alzheimers Dis 2023; 95:1585-1595. [PMID: 37718813 PMCID: PMC10599486 DOI: 10.3233/jad-230491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/19/2023]
Abstract
BACKGROUND Latinos are at higher risk of developing mild cognitive impairment (MCI) and Alzheimer's disease than non-Latino Whites. Acculturation factors may influence this risk, yet there are few studies that have examined associations of acculturation, particularly in the context of socioenvironmental and familial factors, and brain health in older Latinos. OBJECTIVE To examine potential associations between acculturation in context and brain health in older Latinos. METHODS Using three previously established composites of acculturation-in-context, (acculturation-related: nativity status, language preference, acculturation scores; contextually-related socioenvironmental: perceived discrimination, loneliness/social isolation, social network size; and familism), and diffusion-tensor imaging (DTI), associations with white matter structural integrity were examined in 92 Latino adults without dementia participating in one of three epidemiological studies of aging. Linear regression models were used to test associations with DTI-derived metrics (fractional anisotropy, FA; trace) as separate outcomes and acculturation composite scores as individual predictors, while adjusting for age, sex, education, scanner, and white matter hyperintensities (voxelwise and total volumes normalized by intracranial volume). RESULTS Higher scores on the socioenvironmental composite were associated with lower FA in two clusters of left-hemisphere connections. Cluster 1 was dominated by both short association pathways connecting frontal regions and projection pathways connecting frontal regions with the thalamus. Cluster 2 was dominated by long association pathways connecting parietal, frontal, and temporal regions. CONCLUSIONS This study of older Latino adults demonstrated an association between reduced brain white matter integrity and contextually related socioenvironmental experiences known to increase risk of MCI and Alzheimer's disease.
Collapse
Affiliation(s)
- Debra A. Fleischman
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
- Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Konstantinos Arfanakis
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, IL, USA
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA
| | - Shengwei Zhang
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
| | - Sue E. Leurgans
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Lisa L. Barnes
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
- Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA
| | - David A. Bennett
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - David X. Marquez
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL, USA
| | - Melissa Lamar
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA
| |
Collapse
|
7
|
Han SD, Fleischman DA, Yu L, Poole V, Lamar M, Kim N, Leurgans SE, Bennett DA, Arfanakis K, Barnes LL. Cognitive decline and hippocampal functional connectivity within older Black adults. Hum Brain Mapp 2022; 43:5044-5052. [PMID: 36066181 PMCID: PMC9582363 DOI: 10.1002/hbm.26070] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2022] [Revised: 06/26/2022] [Accepted: 08/22/2022] [Indexed: 11/09/2022] Open
Abstract
While there has been a proliferation of neuroimaging studies on cognitive decline in older non-Hispanic White adults, there is a dearth of knowledge regarding neuroimaging correlates of cognitive decline in Black adults. Resting-state functional neuroimaging approaches may be particularly sensitive to early cognitive decline, but there are no studies that we know of that apply this approach to examining associations of brain function to cognition in older Black adults. We investigated the association of cognitive decline with whole-brain voxel-wise functional connectivity to the hippocampus, a key brain region functionally implicated in early Alzheimer's dementia, in 132 older Black adults without dementia participating in the Minority Aging Research Study and Rush Memory and Aging Project, two longitudinal studies of aging that include harmonized annual cognitive assessments and magnetic resonance imaging brain imaging. In models adjusted for demographic factors (age, education, sex), global cognitive decline was associated with functional connectivity of the hippocampus to three clusters in the right and left frontal regions of the dorsolateral prefrontal cortex. In domain-specific analyses, decline in semantic memory was associated with functional connectivity of the hippocampus to bilateral clusters in the precentral gyrus, and decline in perceptual speed was inversely associated with connectivity of the hippocampus to the bilateral intracalcarine cortex and the right fusiform gyrus. These findings elucidate neurobiological mechanisms underlying cognitive decline in older Black adults and may point to specific targets of intervention for Alzheimer's disease.
Collapse
Affiliation(s)
- S. Duke Han
- Department of Family MedicineUniversity of Southern CaliforniaLos AngelesCaliforniaUSA
- Department of NeurologyUniversity of Southern CaliforniaLos AngelesCaliforniaUSA
- Department of PsychologyUniversity of Southern CaliforniaLos AngelesCaliforniaUSA
- School of GerontologyUniversity of Southern CaliforniaLos AngelesCaliforniaUSA
- Department of Psychiatry and Behavioral SciencesRush University Medical CenterChicagoIllinoisUSA
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
| | - Debra A. Fleischman
- Department of Psychiatry and Behavioral SciencesRush University Medical CenterChicagoIllinoisUSA
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Neurological SciencesRush University Medical CenterChicagoIllinoisUSA
| | - Lei Yu
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Neurological SciencesRush University Medical CenterChicagoIllinoisUSA
| | - Victoria Poole
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Orthopedic SurgeryRush University Medical CenterChicagoIllinoisUSA
| | - Melissa Lamar
- Department of Psychiatry and Behavioral SciencesRush University Medical CenterChicagoIllinoisUSA
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
| | - Namhee Kim
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Neurological SciencesRush University Medical CenterChicagoIllinoisUSA
| | - Sue E. Leurgans
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Neurological SciencesRush University Medical CenterChicagoIllinoisUSA
| | - David A. Bennett
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Neurological SciencesRush University Medical CenterChicagoIllinoisUSA
| | - Konstantinos Arfanakis
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Biomedical EngineeringIllinois Institute of TechnologyChicagoIllinoisUSA
- Department of Diagnostic Radiology and Nuclear MedicineRush University Medical CenterChicagoIllinoisUSA
| | - Lisa L. Barnes
- Department of Psychiatry and Behavioral SciencesRush University Medical CenterChicagoIllinoisUSA
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoIllinoisUSA
- Department of Neurological SciencesRush University Medical CenterChicagoIllinoisUSA
| |
Collapse
|
8
|
Boots EA, Feinstein DL, Leurgans S, Aiken-Morgan AT, Fleischman DA, Lamar M, Barnes LL. Acute versus chronic inflammatory markers and cognition in older black adults: Results from the Minority Aging Research Study. Brain Behav Immun 2022; 103:163-170. [PMID: 35439553 PMCID: PMC9704497 DOI: 10.1016/j.bbi.2022.04.014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/16/2021] [Revised: 03/16/2022] [Accepted: 04/14/2022] [Indexed: 10/18/2022] Open
Abstract
Peripheral inflammation is elevated in older Black adults, an elevation which prior work has suggested may be due to chronic stress associated with systemic racism and related adverse cardiovascular health conditions. Inflammation is also involved in the pathogenic processes of dementia; however, limited (and mixed) results exist concerning inflammation and cognitive decline in Black adults. We characterized patterns of inflammation and their role in cognitive decline in 280 older Black adults (age = 72.99 ± 6.00 years; 69.6% female) from the Minority Aging Research Study (MARS) who were without dementia at baseline and followed between 2 and 15 years (mean = 9 years). Participants completed a blood draw at baseline and annual cognitive evaluations. Serum was assayed for 9 peripheral inflammatory markers; 19 neuropsychological test scores were used to create indices of global cognition and five cognitive domains. Principal component analysis with varimax rotation characterized patterns of inflammation with factor loadings > 0.6 per component contributing to two composite scores representing acute/upstream and chronic/downstream inflammation. These composites were used as separate predictors in linear mixed regression models to determine associations with level and change in cognition adjusting for relevant covariates. Higher baseline upstream/acute inflammation associated with lower baseline semantic memory (p = .040) and perceptual speed (p = .046); it was not related to cognitive decline. By contrast, higher baseline downstream/chronic inflammation associated with faster declines in global cognition (p = .010), episodic (p = .027) and working memory (p = .006); it was not related to baseline cognition. For older Black adults, chronic, but not acute, inflammation may be a risk factor for changes in cognition.
Collapse
Affiliation(s)
- Elizabeth A Boots
- Department of Psychology, University of Illinois at Chicago, Chicago, IL 60607, USA; Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612, USA
| | - Douglas L Feinstein
- Department of Anesthesiology, University of Illinois at Chicago, Chicago, IL 60612, USA; Jesse Brown VA Medical Center, Chicago, IL 60612, USA
| | - Sue Leurgans
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612, USA; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL 60612, USA
| | - Adrienne T Aiken-Morgan
- Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill NC 27516, USA
| | - Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612, USA; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL 60612, USA; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA
| | - Melissa Lamar
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612, USA; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL 60612, USA
| | - Lisa L Barnes
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612, USA; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL 60612, USA.
| |
Collapse
|
9
|
Lamar M, Fleischman DA, Leurgans SE, Aggarwal N, Yu L, Kim N, Poole V, Han SD, Arfanakis K, Barnes LL. Relationship of Blood Pressure and White Matter Hyperintensity Burden With Level of and Change in Cognition in Older Black Adults. Psychosom Med 2022; 84:437-445. [PMID: 35100182 PMCID: PMC9064910 DOI: 10.1097/psy.0000000000001059] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
OBJECTIVE Elevations in blood pressure (BP) and associated white matter hyperintensities (WMHs) are chronic comorbid conditions among older Black adults. We investigated whether WMHs modify the association between late-life BP and cognition within older Black adults. METHODS A total of 167 Black adults (age, ~75 years; without dementia at baseline) participating in neuroimaging studies at the Rush Alzheimer's Disease Center were evaluated for BP markers of cardiovascular health, including systolic BP, diastolic BP, pulse pressure, mean arterial pressure (MAP), and hypertension, and were assessed for global and domain-specific cognition at baseline and annually for up to 8 years. WMHs adjusted for intracranial volume were quantified at baseline. RESULTS Models adjusted for relevant confounders and the interaction of these variables with time revealed differential associations between BP markers and baseline cognition; however, only elevated diastolic BP predicted faster cognitive, that is, episodic memory, decline (estimate = -0.002, standard error = 0.0009, p = .002). Although WMH burden did not modify the association between diastolic BP and episodic memory decline, it did interact with diastolic BP to lower episodic memory at baseline (estimate = -0.051, standard error = 0.012, p = .0001); that is, greater WMHs combined with higher diastolic BP resulted in the lowest baseline episodic memory scores. A similar profile was noted for WMHs, MAP, and baseline episodic memory. Hypertension was neither associated with cognition nor modified by WMH burden after multiple comparisons correction. CONCLUSION Late-life diastolic BP was associated with faster rates of episodic memory decline in older Black adults; together with higher WMH burden, it (and MAP) lowered the point at which individuals begin their course of decline toward pathological aging.
Collapse
Affiliation(s)
- Melissa Lamar
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Debra A. Fleischman
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Sue E. Leurgans
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Neelum Aggarwal
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Lei Yu
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Namhee Kim
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Victoria Poole
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, USA
| | - S. Duke Han
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Departments of Family Medicine and Neurology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
- Department of Psychology, University of Southern California, Los Angeles, CA, USA
- School of Gerontology, University of Southern California, Los Angeles, CA, USA
| | - Konstantinos Arfanakis
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA
- Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, IL, USA
| | - Lisa L. Barnes
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL, USA
- Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| |
Collapse
|
10
|
Fleischman DA, Arfanakis K, Leurgans SE, Zhang S, Poole VN, Han SD, Yu L, Lamar M, Kim N, Bennett DA, Barnes LL. Associations of deformation-based brain morphometry with cognitive level and decline within older Blacks without dementia. Neurobiol Aging 2022; 111:35-43. [PMID: 34963062 PMCID: PMC9070546 DOI: 10.1016/j.neurobiolaging.2021.11.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2021] [Revised: 11/04/2021] [Accepted: 11/14/2021] [Indexed: 10/19/2022]
Abstract
Blacks are at higher risk of developing cognitive impairment with age than non-Hispanic Whites, yet most brain morphometry and cognition research is performed with White samples or with mixed samples that control for race or compare across racial groups. A deeper understanding of the within-group variability in associations between brain structure and cognitive decline in Blacks is critically important for designing appropriate outcomes for clinical trials, predicting adverse outcomes, and developing interventions to preserve cognitive function, but no studies have examined these associations longitudinally within Blacks. We performed deformation-based morphometry in 376 older Black participants without dementia and examined associations of deformation-based morphometry with cognitive level and decline for global cognition and five cognitive domains. After correcting for widespread age-associated effects, there remained regions with less tissue and more cerebrospinal fluid associated with level and rate of decline in global cognition, memory, and perceptual speed. Further study is needed to examine the moderators of these associations, identify adverse outcomes predicted by brain morphometry, and deepen knowledge of underlying biological mechanisms.
Collapse
Affiliation(s)
- Debra A. Fleischman
- Rush Alzheimer’s Disease Center, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612,Department of Neurological Sciences, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612,Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612
| | - Konstantinos Arfanakis
- Rush Alzheimer’s Disease Center, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612,Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612,Department of Biomedical Engineering, Illinois Institute of Technology, 10 W. 35th St., Chicago, IL 60616
| | - Sue E. Leurgans
- Rush Alzheimer’s Disease Center, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612,Department of Preventive Medicine, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612
| | - Shengwei Zhang
- Rush Alzheimer’s Disease Center, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612
| | - Victoria N. Poole
- Rush Alzheimer’s Disease Center, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612,Department of Orthopedic Surgery, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612
| | - S. Duke Han
- Rush Alzheimer’s Disease Center, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612,Departments of Family Medicine and Neurology, Keck School of Medicine, University of Southern California, 3551 Trousdale Parkway, Los Angeles, CA 90007,Department of Psychology, University of Southern California, 3551 Trousdale Parkway, Los Angeles, CA 90007,School of Gerontology, University of Southern California, 3551 Trousdale Parkway, Los Angeles, CA 90007
| | - Lei Yu
- Rush Alzheimer’s Disease Center, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612
| | - Melissa Lamar
- Rush Alzheimer’s Disease Center, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612,Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612
| | - Namhee Kim
- Rush Alzheimer’s Disease Center, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612
| | - David A. Bennett
- Rush Alzheimer’s Disease Center, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612
| | - Lisa L. Barnes
- Rush Alzheimer’s Disease Center, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612,Department of Neurological Sciences, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612,Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, 1725 W. Harrison, Chicago IL 60612
| |
Collapse
|
11
|
Balas JS, Phelps EB, Shaw C, Washington E, Glover CM, Ludwig GA, Bennett DA, Fleischman DA, Volgman AS, Aggarwal NT. Leveraging virtual reality to train certified nursing assistants as essential dementia-care personnel in the age of COVID-19. Alzheimers Dement 2022; 17 Suppl 11:e051128. [PMID: 34971052 PMCID: PMC9011608 DOI: 10.1002/alz.051128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Background COVID‐19 has placed an extraordinary and disproportionate level of responsibility and risk on certified nursing assistants (CNAs) caring for persons with dementia (PWD) relative to their training, resources, and compensation levels. Nearly one‐quarter of COVID‐19 deaths in the United States have been nursing home residents and staff. Despite providing the majority of direct care, CNAs are amongst the most under‐resourced and under‐trained frontline workers. Given their essentiality, it is critical to support CNAs during the COVID‐19 pandemic. The purpose of this work is to provide CNAs with a space to strengthen their knowledge and confidence in caring for PWD. This pilot study applies a virtual reality (VR) curriculum to train CNAs regarding the lived experiences of PWD and their loved ones. The VR vignette portrays a Latinx woman, Beatriz, through progressive stages of Alzheimer’s disease. Method Chicago Methodist Senior Services (CMSS) CNAs were recruited (N=7; 86% female, 86% Black) for a seven‐week online training program consisting of 1.5 hours per week. Each class included a didactic lecture and an Embodied Labs VR module depicting a first‐person experience of dementia through a distributive model approach. The program concluded with two recorded focus groups. Participants completed the UCLA Geriatric Attitudes Scale, a dementia knowledge assessment, the Interpersonal Reactivity Index surveys, and a COVID‐19 Impact questionnaire. Current analyses include qualitative content analysis for focus group data and descriptive, quantitative statistics for pre‐and post‐VR intervention surveys. Result Preliminary results demonstrate that CNAs endorsed a positive change in attitudes toward older adults (p=0.069), a deepened understanding of dementia, and increased confidence in caregiving skills. Focus groups allowed CNAs to discuss changes in resident behavior and support one another through a virtual platform during a global pandemic. Conclusion Combining traditional didactic lectures with VR‐based curricula provided CNAs with foundational knowledge and first‐hand experience of dementia pathology. Participants reported greater levels of insight and empathy for PWD. Future aims include expansion of training content to include end‐of‐life conversations, LGBTQIA aging, and Lewy body dementia.
Collapse
Affiliation(s)
| | | | | | | | | | | | - David A Bennett
- Rush Alzheimer's Disease Center, Rush University, Chicago, IL, USA
| | - Debra A Fleischman
- Rush University Medical Center, Chicago, IL, USA.,Rush Alzheimer's Disease Center, Chicago, IL, USA
| | | | - Neelum T Aggarwal
- Rush University Medical Center, Chicago, IL, USA.,Rush Alzheimer's Disease Center, Chicago, IL, USA
| |
Collapse
|
12
|
Lamar M, Barnes LL, Leurgans SE, Fleischman DA, Farfel JM, Bennett DA, Marquez DX. Acculturation in context: The relationship between acculturation and socioenvironmental factors with level of and change in cognition in older Latinos. Alzheimers Dement 2021. [DOI: 10.1002/alz.056238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - Lisa L. Barnes
- Rush Alzheimer's Disease Center, Rush University Medical Center Chicago IL USA
- Department of Neurological Sciences, Rush University Medical Center Chicago IL USA
| | | | | | | | - David A. Bennett
- Rush Alzheimer’s Disease Center and Department of Neurological Sciences, Rush University Medical Center Chicago IL USA
| | - David X. Marquez
- Department of Kinesiology and Nutrition, University of Illinois at Chicago Chicago IL USA
| |
Collapse
|
13
|
Kim N, Arfanakis K, Leurgans SE, Yang J, Fleischman DA, Han SD, Aggarwal NT, Lamar M, Yu L, Poole VN, Bennett DA, Barnes LL. Bootstrap approach for meta-synthesis of MRI findings from multiple scanners. J Neurosci Methods 2021; 360:109229. [PMID: 34052288 DOI: 10.1016/j.jneumeth.2021.109229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2020] [Revised: 05/02/2021] [Accepted: 05/22/2021] [Indexed: 10/21/2022]
Abstract
BACKGROUND Neuroimaging data from large epidemiologic cohort studies often come from multiple scanners. The variations of MRI measurements due to differences in magnetic field strength, image acquisition protocols, and scanner vendors can influence the interpretation of aggregated data. The purpose of the present study was to compare methods that meta-analyze findings from a small number of different MRI scanners. METHODS We proposed a bootstrap resampling method using individual participant data and compared it with two common random effects meta-analysis methods, DerSimonian-Laird and Hartung-Knapp, and a conventional pooling method that combines MRI data from different scanners. We first performed simulations to compare the power and coverage probabilities of the four methods in the absence and presence of scanner effects on measurements. We then examined the association of age with white matter hyperintensity (WMH) volumes from 787 participants. RESULTS In simulations, the bootstrap approach performed better than the other three methods in terms of coverage probability and power when scanner differences were present. However, the bootstrap approach was consistent with pooling, the optimal approach, when scanner differences were absent. In the association of age with WMH volume, we observed that age was significantly associated with WMH volumes using the bootstrap approach, pooling, and the DerSimonian-Laird method, but not using the Hartung-Knapp method (p < 0.0001 for the bootstrap approach, DerSimonian-Laird, and pooling but p = 0.1439 for the Hartung-Knapp approach). CONCLUSION The bootstrap approach using individual participant data is suitable for integrating outcomes from multiple MRI scanners regardless of absence or presence of scanner effects on measurements.
Collapse
Affiliation(s)
- Namhee Kim
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, United States; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, 60612, United States.
| | - Konstantinos Arfanakis
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, United States; Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, 60616, United States; Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, IL, 60612, United States
| | - Sue E Leurgans
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, United States; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, 60612, United States
| | - Jingyun Yang
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, United States; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, 60612, United States
| | - Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, United States; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, 60612, United States; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL 60612, United States
| | - S Duke Han
- Department of Family Medicine, University of Southern California, Los Angeles, CA, 90089, United States; Department of Neurology, University of Southern California, Los Angeles, CA, 90089, United States; Department of Psychology, University of Southern California, Los Angeles, CA, 90089, United States; School of Gerontology, University of Southern California, Los Angeles, CA, 90089, United States
| | - Neelum T Aggarwal
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, United States; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, 60612, United States
| | - Melissa Lamar
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, United States; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL 60612, United States
| | - Lei Yu
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, United States; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, 60612, United States
| | - Victoria N Poole
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, United States; Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL, 60612, United States
| | - David A Bennett
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, United States; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, 60612, United States
| | - Lisa L Barnes
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, 60612, United States; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, 60612, United States; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL 60612, United States
| |
Collapse
|
14
|
Lamar M, Barnes LL, Leurgans SE, Fleischman DA, Farfel JM, Bennett DA, Marquez DX. Acculturation in Context: The Relationship Between Acculturation and Socioenvironmental Factors With Level of and Change in Cognition in Older Latinos. J Gerontol B Psychol Sci Soc Sci 2020; 76:e129-e139. [PMID: 32918471 DOI: 10.1093/geronb/gbaa156] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2020] [Indexed: 12/17/2022] Open
Abstract
OBJECTIVES Latinos are 1.5 times as likely to develop Alzheimer's dementia as non-Latino Whites. This health disparity may arise from multiple influences with culturally relevant factors receiving increasing attention. Models of acculturation stress the importance of considering acculturation-related factors within the context of socioenvironmental factors to better capture the Latino experience in the United States. METHODS We measured 10 acculturation and contextually-related variables in 199 Latinos (age 69.7 years) without dementia participating in Rush Alzheimer's Disease Center studies. We tested the relationship between these variables via Principal Component Analysis (PCA), then investigated how resulting components associated with level of and longitudinal change in global and domain-specific cognition using separate linear mixed-effects models adjusted for relevant confounders and their interactions with time. RESULTS The PCA revealed a 3-factor unrotated solution (variance explained ~70%). Factor 1, representing acculturation-related aspects of nativity, language- and social-based acculturation, was positively associated with level, but not change, in global cognition, semantic memory, and perceptual speed. Factor 2, representing contextually-related socioenvironmental experiences of discrimination, social isolation, and social networks, was negatively associated with level of global cognition, episodic and working memory, and faster longitudinal decline in visuospatial ability. Factor 3 (familism only) did not associate with level or change in any cognitive outcome. DISCUSSION Acculturation- and contextually-related factors differentiated from each other and differentially contributed to cognition and cognitive decline in older Latinos. Providers should query acculturation and lived experiences when evaluating cognition in older Latinos.
Collapse
Affiliation(s)
- Melissa Lamar
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois.,Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, Illinois
| | - Lisa L Barnes
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois.,Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, Illinois
| | - Sue E Leurgans
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois.,Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois
| | - Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois.,Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, Illinois
| | - Jose M Farfel
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois.,Department of Pathology, Rush University Medical Center, Chicago, Illinois
| | - David A Bennett
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois.,Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois
| | - David X Marquez
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois.,Department of Kinesiology and Nutrition, University of Illinois at Chicago
| |
Collapse
|
15
|
Arvanitakis Z, Capuano AW, Brey R, Fleischman DA, Arfanakis K, Buchman AS, Schneider JA, Levine SR, Bennett DA. Antiphospholipid Antibodies: Cognitive and Motor Decline, Neuroimaging and Neuropathology. Neuroepidemiology 2019; 53:100-107. [PMID: 31067547 DOI: 10.1159/000500157] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2018] [Accepted: 04/03/2019] [Indexed: 02/03/2023] Open
Abstract
BACKGROUND Few data are available on associations of antiphospholipid (aPL) antibodies with cognitive and motor decline in aging, and cerebrovascular disease on in vivo neuroimaging and postmortem neuropathology. METHODS This longitudinal, clinical-pathologic study (aPL antibodies, brain infarcts, and cognitive and motor decline in aging), was derived from 2 ongoing community-based cohort studies. A panel of 3 aPL antibodies was assayed in serum from 956 older individuals (mean age = 81.1 years; 72% women). Serum was also tested in a subset for markers of inflammation (C-reactive protein [CRP]) and blood-brain barrier breakdown (matrix metalloproteinases, MMPs). Annual clinical evaluations documented cognitive (17 neuropsychological tests) and motor function including parkinsonism. Cerebrovascular disease data were derived from in vivo neuroimaging and postmortem neuropathologic evaluations (699 individuals). We examined associations of aPL with cognitive and motor decline, other serum markers, neuroimaging, and neuropathology. RESULTS Of 956 individuals, 197 (20.6%) had aPL positivity, defined as positivity on any of the assays, at the time of first measurement. During a mean follow-up of 6.6 years (SD 4), overall aPL positivity was not associated with change in global cognition (estimate = -0.005, SE 0.011; p = 0.622) or parkinsonian signs (estimate = -0.003, SE 0.017; p = 0.860). aPL were not associated with serum CRP or MMPs (both p > 0.268). aPL were not associated with in vivo brain magnetic resonance imaging white matter hyperintensities or infarcts (both p > 0.376). Among those autopsied, aPL were not associated with pathologically confirmed brain infarcts, or cerebral atherosclerosis or arteriolosclerosis (all p≥ 0.447). CONCLUSIONS In older individuals followed longitudinally, aPL do not relate to cognitive or motor decline, inflammation, or cerebrovascular disease on in vivo neuroimaging or postmortem neuropathology.
Collapse
Affiliation(s)
- Zoe Arvanitakis
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA, .,Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA,
| | - Ana W Capuano
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.,Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
| | - Robin Brey
- Department of Neurology, University of Texas Health Sciences Center at San Antonio, San Antonio, Texas, USA
| | - Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.,Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.,Department of Behavioral Sciences, Rush University Medical Center, Chicago, Illinois, USA
| | - Konstantinos Arfanakis
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.,Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois, USA
| | - Aron S Buchman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.,Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
| | - Julie A Schneider
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.,Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.,Department of Pathology, Rush University Medical Center, Chicago, Illinois, USA
| | - Steven R Levine
- Department of Neurology, State University of New York College of Medicine, Downstate Medical Center, and Kings County Hospital Center, Brooklyn, New York, USA
| | - David A Bennett
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.,Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
| |
Collapse
|
16
|
Lamar M, Arfanakis K, Yu L, Zhang S, Han SD, Fleischman DA, Bennett DA, Boyle PA. P4‐166: WHITE MATTER CORRELATES OF SUSCEPTIBILITY TO SCAM IN COMMUNITY‐DWELLING OLDER ADULTS. Alzheimers Dement 2018. [DOI: 10.1016/j.jalz.2018.06.2571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- Melissa Lamar
- Rush Alzheimer's Disease CenterRush University Medical CenterChicagoILUSA
| | | | - Lei Yu
- Rush University Medical CenterChicagoILUSA
| | | | - S. Duke Han
- Rush University Medical CenterChicagoILUSA
- VA Long Beach Healthcare SystemLong BeachCAUSA
| | | | | | | |
Collapse
|
17
|
Fleischman DA, Arfanakis K, Leurgans S, Keating SM, Lamar M, Bennett DA, Adeyemi OM, Barnes LL. Neopterin is associated with hippocampal subfield volumes and cognition in HIV. Neurol Neuroimmunol Neuroinflamm 2018; 5:e467. [PMID: 29904644 PMCID: PMC5999345 DOI: 10.1212/nxi.0000000000000467] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/16/2017] [Accepted: 04/04/2018] [Indexed: 11/27/2022]
Abstract
Objective HIV infection sets off an immediate immune response and inflammatory cascade that can lead to neuronal injury and cognitive impairment, but the relationship between immune markers, regional brain volumes, and cognition remains understudied in HIV-infected adults. Methods Cross-sectional associations were examined between serum immune markers of activation (neopterin) and inflammation (interleukin [IL]-1β, IL-6, tumor necrosis factor alpha, and C-reactive protein) with regional brain volumes (cortical, subcortical, total gray matter, hippocampus, and subfields) and cognition in 66 HIV-infected, virally suppressed, adults who underwent 3.0-T MRI as part of the Research Core of the Rush Center of Excellence on Disparities in HIV and Aging. Immune markers were assayed from frozen plasma, values were entered into linear regression models as predictors of regional brain volumes, and interactive effects of immune response and regional brain volumes on cognition were examined. Results No inflammatory marker was associated with any regional brain volume. Higher neopterin level was associated with lower total hippocampal, presubiculum, and cornu ammonis (CA) subfield volumes. Higher neopterin level and lower total hippocampal volume were independently associated with lower episodic memory, and neopterin level fully mediated the effect of hippocampal atrophy on episodic memory. Higher neopterin levels were associated with lower presubiculum, CA1, and CA4/dentate volumes and lower semantic memory, working memory, and global cognition. Conclusion Immune activation in response to HIV infection, measured by neopterin, has a deleterious and targeted effect on regional brain structure, which can be visualized with clinically available MRI measures of hippocampus and its subfields, and this effect is associated with lower cognitive function.
Collapse
Affiliation(s)
- Debra A Fleischman
- Rush Alzheimer's Disease Center (D.A.F., K.A., S.L., M.L., D.A.B., L.L.B.), Rush University Medical Center; the Department of Neurological Sciences (D.A.F., S.L., M.L., D.A.B., L.L.B.), the Department of Behavioral Sciences (D.A.F., M.L., L.L.B.), the Department of Preventive Medicine (S.L.), the Department of Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center; Ruth M. Rothstein CORE Center (O.M.A.); the Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago; the Blood Systems Research Institute (S.M.K.), San Francisco, CA; and the University of California at San Francisco (S.M.K.), Laboratory Medicine
| | - Konstantinos Arfanakis
- Rush Alzheimer's Disease Center (D.A.F., K.A., S.L., M.L., D.A.B., L.L.B.), Rush University Medical Center; the Department of Neurological Sciences (D.A.F., S.L., M.L., D.A.B., L.L.B.), the Department of Behavioral Sciences (D.A.F., M.L., L.L.B.), the Department of Preventive Medicine (S.L.), the Department of Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center; Ruth M. Rothstein CORE Center (O.M.A.); the Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago; the Blood Systems Research Institute (S.M.K.), San Francisco, CA; and the University of California at San Francisco (S.M.K.), Laboratory Medicine
| | - Sue Leurgans
- Rush Alzheimer's Disease Center (D.A.F., K.A., S.L., M.L., D.A.B., L.L.B.), Rush University Medical Center; the Department of Neurological Sciences (D.A.F., S.L., M.L., D.A.B., L.L.B.), the Department of Behavioral Sciences (D.A.F., M.L., L.L.B.), the Department of Preventive Medicine (S.L.), the Department of Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center; Ruth M. Rothstein CORE Center (O.M.A.); the Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago; the Blood Systems Research Institute (S.M.K.), San Francisco, CA; and the University of California at San Francisco (S.M.K.), Laboratory Medicine
| | - Sheila M Keating
- Rush Alzheimer's Disease Center (D.A.F., K.A., S.L., M.L., D.A.B., L.L.B.), Rush University Medical Center; the Department of Neurological Sciences (D.A.F., S.L., M.L., D.A.B., L.L.B.), the Department of Behavioral Sciences (D.A.F., M.L., L.L.B.), the Department of Preventive Medicine (S.L.), the Department of Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center; Ruth M. Rothstein CORE Center (O.M.A.); the Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago; the Blood Systems Research Institute (S.M.K.), San Francisco, CA; and the University of California at San Francisco (S.M.K.), Laboratory Medicine
| | - Melissa Lamar
- Rush Alzheimer's Disease Center (D.A.F., K.A., S.L., M.L., D.A.B., L.L.B.), Rush University Medical Center; the Department of Neurological Sciences (D.A.F., S.L., M.L., D.A.B., L.L.B.), the Department of Behavioral Sciences (D.A.F., M.L., L.L.B.), the Department of Preventive Medicine (S.L.), the Department of Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center; Ruth M. Rothstein CORE Center (O.M.A.); the Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago; the Blood Systems Research Institute (S.M.K.), San Francisco, CA; and the University of California at San Francisco (S.M.K.), Laboratory Medicine
| | - David A Bennett
- Rush Alzheimer's Disease Center (D.A.F., K.A., S.L., M.L., D.A.B., L.L.B.), Rush University Medical Center; the Department of Neurological Sciences (D.A.F., S.L., M.L., D.A.B., L.L.B.), the Department of Behavioral Sciences (D.A.F., M.L., L.L.B.), the Department of Preventive Medicine (S.L.), the Department of Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center; Ruth M. Rothstein CORE Center (O.M.A.); the Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago; the Blood Systems Research Institute (S.M.K.), San Francisco, CA; and the University of California at San Francisco (S.M.K.), Laboratory Medicine
| | - Oluwatoyin M Adeyemi
- Rush Alzheimer's Disease Center (D.A.F., K.A., S.L., M.L., D.A.B., L.L.B.), Rush University Medical Center; the Department of Neurological Sciences (D.A.F., S.L., M.L., D.A.B., L.L.B.), the Department of Behavioral Sciences (D.A.F., M.L., L.L.B.), the Department of Preventive Medicine (S.L.), the Department of Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center; Ruth M. Rothstein CORE Center (O.M.A.); the Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago; the Blood Systems Research Institute (S.M.K.), San Francisco, CA; and the University of California at San Francisco (S.M.K.), Laboratory Medicine
| | - Lisa L Barnes
- Rush Alzheimer's Disease Center (D.A.F., K.A., S.L., M.L., D.A.B., L.L.B.), Rush University Medical Center; the Department of Neurological Sciences (D.A.F., S.L., M.L., D.A.B., L.L.B.), the Department of Behavioral Sciences (D.A.F., M.L., L.L.B.), the Department of Preventive Medicine (S.L.), the Department of Diagnostic Radiology and Nuclear Medicine (K.A.), Rush University Medical Center; Ruth M. Rothstein CORE Center (O.M.A.); the Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago; the Blood Systems Research Institute (S.M.K.), San Francisco, CA; and the University of California at San Francisco (S.M.K.), Laboratory Medicine
| |
Collapse
|
18
|
Arvanitakis Z, Leurgans SE, Fleischman DA, Schneider JA, Rajan KB, Pruzin JJ, Shah RC, Evans DA, Barnes LL, Bennett DA. Memory complaints, dementia, and neuropathology in older blacks and whites. Ann Neurol 2018; 83:718-729. [PMID: 29466839 PMCID: PMC5912967 DOI: 10.1002/ana.25189] [Citation(s) in RCA: 32] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2017] [Revised: 02/16/2018] [Accepted: 02/19/2018] [Indexed: 01/16/2023]
Abstract
OBJECTIVE To determine relationships of memory complaints to cognitive function and decline, incident dementia, and neurodegenerative and other neuropathologies, as well as the population-attributable risk for dementia in older black and white persons. METHODS A total of 4,015 community-based persons (28% black; 74% women; mean baseline age = 78 years) were enrolled in 1 of 4 longitudinal cohort studies, and another 2,937 in a population-based cohort. Memory scores, assessed using 2 questions (5-point Likert scales) were categorized as complaints present or absent. Global cognition and 5 cognitive domains were derived from annual neuropsychological tests. Dementia was assessed from these tests and additional data. Neuropathologic data were available for 1,350 deceased subjects with brain autopsies. Regression and mixed effects models were used to examine relationships of memory complaints to cognition and neuropathology. RESULTS Baseline memory complaints (n = 1,310; 33% of 4,015) were associated with lower cognition and faster decline in all domains (global score estimate = -0.032, standard error = 0.004, p < 0.0001), during a mean follow-up of 6 (standard deviation = 2) years. Persons with memory complaints had higher dementia risk (hazard ratio = 1.64, 95% confidence interval [CI] = 1.42-1.89) and odds of pathologic Alzheimer disease (odds ratio [OR] = 1.96, 95% CI = 1.51-2.54), neocortical Lewy bodies (OR = 2.47, 95% CI = 1.54-3.96), and other neurodegenerative pathologies. Results for dementia risk were similar among blacks and whites. Among 2,937 older persons in a population-based cohort with similar data, the population-attributable risk for incident dementia due to memory complaints was 14.0% (95% CI = 2.6-23.0), and did not vary between the black and white groups. INTERPRETATION Memory complaints are common in older black and white persons, and relate to cognitive decline, dementia risk, and neurodegenerative pathologies. Ann Neurol 2018;83:718-729.
Collapse
Affiliation(s)
- Zoe Arvanitakis
- Rush Alzheimer's Disease Center.,Department of Neurological Sciences
| | - Sue E Leurgans
- Rush Alzheimer's Disease Center.,Department of Neurological Sciences
| | - Debra A Fleischman
- Rush Alzheimer's Disease Center.,Department of Neurological Sciences.,Department of Behavioral Sciences
| | - Julie A Schneider
- Rush Alzheimer's Disease Center.,Department of Neurological Sciences.,Department of Pathology
| | | | - Jeremy J Pruzin
- Rush Alzheimer's Disease Center.,Department of Neurological Sciences
| | - Raj C Shah
- Rush Alzheimer's Disease Center.,Department of Family Medicine, Rush University Medical Center, Chicago, IL
| | | | - Lisa L Barnes
- Rush Alzheimer's Disease Center.,Department of Neurological Sciences.,Department of Behavioral Sciences
| | - David A Bennett
- Rush Alzheimer's Disease Center.,Department of Neurological Sciences
| |
Collapse
|
19
|
Duke Han S, Boyle PA, Yu L, Arfanakis K, James BD, Fleischman DA, Bennett DA. Grey matter correlates of susceptibility to scams in community-dwelling older adults. Brain Imaging Behav 2017; 10:524-32. [PMID: 26100658 DOI: 10.1007/s11682-015-9422-4] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Susceptibility to scams is a significant issue among older adults, even among those with intact cognition. Age-related changes in brain macrostructure may be associated with susceptibility to scams; however, this has yet to be explored. Based on previous work implicating frontal and temporal lobe functioning as important in decision making, we tested the hypothesis that susceptibility to scams is associated with smaller grey matter volume in frontal and temporal lobe regions in a large community-dwelling cohort of non-demented older adults. Participants (N = 327, mean age = 81.55, mean education = 15.30, 78.9 % female) completed a self-report measure used to assess susceptibility to scams and an MRI brain scan. Results indicated an inverse association between overall grey matter and susceptibility to scams in models adjusted for age, education, and sex; and in models further adjusted for cognitive function. No significant associations were observed for white matter, cerebrospinal fluid, or total brain volume. Models adjusted for age, education, and sex revealed seven clusters showing smaller grey matter in the right parahippocampal/hippocampal/fusiform, left middle temporal, left orbitofrontal, right ventromedial prefrontal, right middle temporal, right precuneus, and right dorsolateral prefrontal regions. In models further adjusted for cognitive function, results revealed three significant clusters showing smaller grey matter in the right parahippocampal/hippocampal/fusiform, right hippocampal, and right middle temporal regions. Lower grey matter concentration in specific brain regions may be associated with susceptibility to scams, even after adjusting for cognitive ability. Future research is needed to determine whether grey matter reductions in these regions may be a biomarker for susceptibility to scams in old age.
Collapse
Affiliation(s)
- S Duke Han
- Rush Alzheimer's Disease Center, Rush University Medical Center, 600 S. Paulina St., Suite 1022, Chicago, IL, 60612, USA. .,Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL, 60612, USA. .,Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, 60612, USA. .,Mental Health Care Group, VA Long Beach Healthcare System, Long Beach, CA, 90822, USA.
| | - Patricia A Boyle
- Rush Alzheimer's Disease Center, Rush University Medical Center, 600 S. Paulina St., Suite 1022, Chicago, IL, 60612, USA.,Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL, 60612, USA
| | - Lei Yu
- Rush Alzheimer's Disease Center, Rush University Medical Center, 600 S. Paulina St., Suite 1022, Chicago, IL, 60612, USA.,Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, 60612, USA
| | - Konstantinos Arfanakis
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, 60612, USA.,Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, IL, 60612, USA
| | - Bryan D James
- Rush Alzheimer's Disease Center, Rush University Medical Center, 600 S. Paulina St., Suite 1022, Chicago, IL, 60612, USA.,Department of Internal Medicine, Rush University Medical Center, Chicago, IL, 60612, USA
| | - Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, 600 S. Paulina St., Suite 1022, Chicago, IL, 60612, USA.,Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL, 60612, USA.,Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, 60612, USA
| | - David A Bennett
- Rush Alzheimer's Disease Center, Rush University Medical Center, 600 S. Paulina St., Suite 1022, Chicago, IL, 60612, USA.,Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, 60612, USA
| |
Collapse
|
20
|
Thaker AA, Weinberg BD, Dillon WP, Hess CP, Cabral HJ, Fleischman DA, Leurgans SE, Bennett DA, Hyman BT, Albert MS, Killiany RJ, Fischl B, Dale AM, Desikan RS. Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid Pathology. AJNR Am J Neuroradiol 2017; 38:961-965. [PMID: 28279988 DOI: 10.3174/ajnr.a5133] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2016] [Accepted: 01/10/2017] [Indexed: 12/14/2022]
Abstract
BACKGROUND AND PURPOSE The entorhinal cortex, a critical gateway between the neocortex and hippocampus, is one of the earliest regions affected by Alzheimer disease-associated neurofibrillary tangle pathology. Although our prior work has automatically delineated an MR imaging-based measure of the entorhinal cortex, whether antemortem entorhinal cortex thickness is associated with postmortem tangle burden within the entorhinal cortex is still unknown. Our objective was to evaluate the relationship between antemortem MRI measures of entorhinal cortex thickness and postmortem neuropathological measures. MATERIALS AND METHODS We evaluated 50 participants from the Rush Memory and Aging Project with antemortem structural T1-weighted MR imaging and postmortem neuropathologic assessments. Here, we focused on thickness within the entorhinal cortex as anatomically defined by our previously developed MR imaging parcellation system (Desikan-Killiany Atlas in FreeSurfer). Using linear regression, we evaluated the association between entorhinal cortex thickness and tangles and amyloid-β load within the entorhinal cortex and medial temporal and neocortical regions. RESULTS We found a significant relationship between antemortem entorhinal cortex thickness and entorhinal cortex (P = .006) and medial temporal lobe tangles (P = .002); we found no relationship between entorhinal cortex thickness and entorhinal cortex (P = .09) and medial temporal lobe amyloid-β (P = .09). We also found a significant association between entorhinal cortex thickness and cortical tangles (P = .003) and amyloid-β (P = .01). We found no relationship between parahippocampal gyrus thickness and entorhinal cortex (P = .31) and medial temporal lobe tangles (P = .051). CONCLUSIONS Our findings indicate that entorhinal cortex-associated in vivo cortical thinning may represent a marker of postmortem medial temporal and neocortical Alzheimer disease pathology.
Collapse
Affiliation(s)
- A A Thaker
- From the Department of Radiology (A.A.T.), University of Colorado School of Medicine, Aurora, Colorado
| | - B D Weinberg
- Department of Radiology and Imaging Sciences (B.D.W.), Emory University Hospital, Atlanta, Georgia
| | - W P Dillon
- Neuroradiology Section (W.P.D., C.P.H., R.S.D.), Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California
| | - C P Hess
- Neuroradiology Section (W.P.D., C.P.H., R.S.D.), Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California
| | | | - D A Fleischman
- Rush Alzheimer's Disease Center (D.A.F., S.E.L., D.A.B.), Rush University Medical Center, Chicago, Illinois
| | - S E Leurgans
- Rush Alzheimer's Disease Center (D.A.F., S.E.L., D.A.B.), Rush University Medical Center, Chicago, Illinois
| | - D A Bennett
- Rush Alzheimer's Disease Center (D.A.F., S.E.L., D.A.B.), Rush University Medical Center, Chicago, Illinois
| | - B T Hyman
- Department of Neurology (B.T.H.), Massachusetts General Hospital, Boston, Massachusetts
| | - M S Albert
- Department of Neurology and Division of Cognitive Neurosciences (M.S.A.), Johns Hopkins University, Baltimore, Maryland
| | - R J Killiany
- Anatomy and Neurobiology (R.J.K.), Boston University School of Public Health, Boston, Massachusetts
| | - B Fischl
- Athinoula A. Martinos Center for Biomedical Imaging (B.F.), Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts.,Computer Science and Artificial Intelligence Laboratory (B.F.), Massachusetts Institute of Technology, Cambridge, Massachusetts
| | - A M Dale
- Departments of Radiology (A.M.D.), Cognitive Sciences and Neurosciences, University of California, San Diego, La Jolla, California
| | - R S Desikan
- Neuroradiology Section (W.P.D., C.P.H., R.S.D.), Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California
| |
Collapse
|
21
|
Hibar DP, Adams HHH, Jahanshad N, Chauhan G, Stein JL, Hofer E, Renteria ME, Bis JC, Arias-Vasquez A, Ikram MK, Desrivières S, Vernooij MW, Abramovic L, Alhusaini S, Amin N, Andersson M, Arfanakis K, Aribisala BS, Armstrong NJ, Athanasiu L, Axelsson T, Beecham AH, Beiser A, Bernard M, Blanton SH, Bohlken MM, Boks MP, Bralten J, Brickman AM, Carmichael O, Chakravarty MM, Chen Q, Ching CRK, Chouraki V, Cuellar-Partida G, Crivello F, Den Braber A, Doan NT, Ehrlich S, Giddaluru S, Goldman AL, Gottesman RF, Grimm O, Griswold ME, Guadalupe T, Gutman BA, Hass J, Haukvik UK, Hoehn D, Holmes AJ, Hoogman M, Janowitz D, Jia T, Jørgensen KN, Karbalai N, Kasperaviciute D, Kim S, Klein M, Kraemer B, Lee PH, Liewald DCM, Lopez LM, Luciano M, Macare C, Marquand AF, Matarin M, Mather KA, Mattheisen M, McKay DR, Milaneschi Y, Muñoz Maniega S, Nho K, Nugent AC, Nyquist P, Loohuis LMO, Oosterlaan J, Papmeyer M, Pirpamer L, Pütz B, Ramasamy A, Richards JS, Risacher SL, Roiz-Santiañez R, Rommelse N, Ropele S, Rose EJ, Royle NA, Rundek T, Sämann PG, Saremi A, Satizabal CL, Schmaal L, Schork AJ, Shen L, Shin J, Shumskaya E, Smith AV, Sprooten E, Strike LT, Teumer A, Tordesillas-Gutierrez D, Toro R, Trabzuni D, Trompet S, Vaidya D, Van der Grond J, Van der Lee SJ, Van der Meer D, Van Donkelaar MMJ, Van Eijk KR, Van Erp TGM, Van Rooij D, Walton E, Westlye LT, Whelan CD, Windham BG, Winkler AM, Wittfeld K, Woldehawariat G, Wolf C, Wolfers T, Yanek LR, Yang J, Zijdenbos A, Zwiers MP, Agartz I, Almasy L, Ames D, Amouyel P, Andreassen OA, Arepalli S, Assareh AA, Barral S, Bastin ME, Becker DM, Becker JT, Bennett DA, Blangero J, van Bokhoven H, Boomsma DI, Brodaty H, Brouwer RM, Brunner HG, Buckner RL, Buitelaar JK, Bulayeva KB, Cahn W, Calhoun VD, Cannon DM, Cavalleri GL, Cheng CY, Cichon S, Cookson MR, Corvin A, Crespo-Facorro B, Curran JE, Czisch M, Dale AM, Davies GE, De Craen AJM, De Geus EJC, De Jager PL, De Zubicaray GI, Deary IJ, Debette S, DeCarli C, Delanty N, Depondt C, DeStefano A, Dillman A, Djurovic S, Donohoe G, Drevets WC, Duggirala R, Dyer TD, Enzinger C, Erk S, Espeseth T, Fedko IO, Fernández G, Ferrucci L, Fisher SE, Fleischman DA, Ford I, Fornage M, Foroud TM, Fox PT, Francks C, Fukunaga M, Gibbs JR, Glahn DC, Gollub RL, Göring HHH, Green RC, Gruber O, Gudnason V, Guelfi S, Håberg AK, Hansell NK, Hardy J, Hartman CA, Hashimoto R, Hegenscheid K, Heinz A, Le Hellard S, Hernandez DG, Heslenfeld DJ, Ho BC, Hoekstra PJ, Hoffmann W, Hofman A, Holsboer F, Homuth G, Hosten N, Hottenga JJ, Huentelman M, Pol HEH, Ikeda M, Jack Jr CR, Jenkinson M, Johnson R, Jönsson EG, Jukema JW, Kahn RS, Kanai R, Kloszewska I, Knopman DS, Kochunov P, Kwok JB, Lawrie SM, Lemaître H, Liu X, Longo DL, Lopez OL, Lovestone S, Martinez O, Martinot JL, Mattay VS, McDonald C, McIntosh AM, McMahon FJ, McMahon KL, Mecocci P, Melle I, Meyer-Lindenberg A, Mohnke S, Montgomery GW, Morris DW, Mosley TH, Mühleisen TW, Müller-Myhsok B, Nalls MA, Nauck M, Nichols TE, Niessen WJ, Nöthen MM, Nyberg L, Ohi K, Olvera RL, Ophoff RA, Pandolfo M, Paus T, Pausova Z, Penninx BWJH, Pike GB, Potkin SG, Psaty BM, Reppermund S, Rietschel M, Roffman JL, Romanczuk-Seiferth N, Rotter JI, Ryten M, Sacco RL, Sachdev PS, Saykin AJ, Schmidt R, Schmidt H, Schofield PR, Sigursson S, Simmons A, Singleton A, Sisodiya SM, Smith C, Smoller JW, Soininen H, Steen VM, Stott DJ, Sussmann JE, Thalamuthu A, Toga AW, Traynor BJ, Troncoso J, Tsolaki M, Tzourio C, Uitterlinden AG, Hernández MCV, Van der Brug M, van der Lugt A, van der Wee NJA, Van Haren NEM, van 't Ent D, Van Tol MJ, Vardarajan BN, Vellas B, Veltman DJ, Völzke H, Walter H, Wardlaw JM, Wassink TH, Weale ME, Weinberger DR, Weiner MW, Wen W, Westman E, White T, Wong TY, Wright CB, Zielke RH, Zonderman AB, Martin NG, Van Duijn CM, Wright MJ, Longstreth WT, Schumann G, Grabe HJ, Franke B, Launer LJ, Medland SE, Seshadri S, Thompson PM, Ikram MA. Novel genetic loci associated with hippocampal volume. Nat Commun 2017; 8:13624. [PMID: 28098162 PMCID: PMC5253632 DOI: 10.1038/ncomms13624] [Citation(s) in RCA: 183] [Impact Index Per Article: 26.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2016] [Accepted: 10/18/2016] [Indexed: 12/17/2022] Open
Abstract
The hippocampal formation is a brain structure integrally involved in episodic memory, spatial navigation, cognition and stress responsiveness. Structural abnormalities in hippocampal volume and shape are found in several common neuropsychiatric disorders. To identify the genetic underpinnings of hippocampal structure here we perform a genome-wide association study (GWAS) of 33,536 individuals and discover six independent loci significantly associated with hippocampal volume, four of them novel. Of the novel loci, three lie within genes (ASTN2, DPP4 and MAST4) and one is found 200 kb upstream of SHH. A hippocampal subfield analysis shows that a locus within the MSRB3 gene shows evidence of a localized effect along the dentate gyrus, subiculum, CA1 and fissure. Further, we show that genetic variants associated with decreased hippocampal volume are also associated with increased risk for Alzheimer's disease (rg=-0.155). Our findings suggest novel biological pathways through which human genetic variation influences hippocampal volume and risk for neuropsychiatric illness.
Collapse
Affiliation(s)
- Derrek P. Hibar
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
| | - Hieab H. H. Adams
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
- Department of Radiology and Nuclear Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands
| | - Neda Jahanshad
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
| | - Ganesh Chauhan
- INSERM Unit U1219, University of Bordeaux, 33076 Bordeaux, France
| | - Jason L. Stein
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
- Department of Genetics & UNC Neuroscience Center, University of North Carolina (UNC), Chapel Hill, North Carolina, 27599, USA
| | - Edith Hofer
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Auenbruggerplatz 22, 8036 Graz, Austria
- Institute of Medical Informatics, Statistics and Documentation, Medical University Graz, Auenbruggerplatz 22, 8036 Graz, Austria
| | - Miguel E. Renteria
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia
| | - Joshua C. Bis
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, 1730 Minor Avenue/Suite 1360. Seattle, Washington 98101, USA
| | - Alejandro Arias-Vasquez
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Department of Psychiatry, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Department of Cognitive Neuroscience, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - M. Kamran Ikram
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
- Academic Medicine Research Institute, Duke-NUS Graduate Medical School, Singapore, 169857, Singapore
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, 168751, Singapore
- Memory Aging & Cognition Centre (MACC), National University Health System, Singapore, 119228, Singapore
- Department of Pharmacology, National University of Singapore, Singapore, 119077, Singapore
| | - Sylvane Desrivières
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK
| | - Meike W. Vernooij
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
- Department of Radiology and Nuclear Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands
| | - Lucija Abramovic
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Saud Alhusaini
- Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4
- The Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland
| | - Najaf Amin
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
| | - Micael Andersson
- Department of Integrative Medical Biology and Umeå Center for Functional Brain Imaging, Umeå University, 901 87 Umeå, Sweden
| | - Konstantinos Arfanakis
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois 60616, USA
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois 60612, USA
- Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, Illinois 60616, USA
| | - Benjamin S. Aribisala
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK
- Department of Computer Science, Lagos State University, Lagos, P.M.B. 01 LASU, Nigeria
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
| | - Nicola J. Armstrong
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
- Mathematics and Statistics, Murdoch University, Perth, Western Australia, 6150, Australia
| | - Lavinia Athanasiu
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
- NORMENT—KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, 0424 Oslo, Norway
| | - Tomas Axelsson
- Department of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Box 1432, SE-751 44 Uppsala, Sweden
| | - Ashley H. Beecham
- Dr John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
| | - Alexa Beiser
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts,02118, USA
- Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts 02118 USA
- Framingham Heart Study, 17 Mount Wayte Avenue, Framingham, Massachusetts 01703 USA
| | - Manon Bernard
- Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada M5G 1X8
| | - Susan H. Blanton
- Dr John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
| | - Marc M. Bohlken
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Marco P. Boks
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Janita Bralten
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Adam M. Brickman
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain; G.H. Sergievsky Center; Department of Neurology. Columbia University Medical Center, 639 West 1168th Street, New York, New York 10032, USA
| | - Owen Carmichael
- Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808, USA
| | - M. Mallar Chakravarty
- Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal, Quebec, Canada H4H 1R3
- Department of Psychiatry and Biomedical Engineering, McGill University, Montreal, Quebec, Canada H3A 2B4
| | - Qiang Chen
- Lieber Institute for Brain Development, Baltimore, Maryland 21205, USA
| | - Christopher R. K. Ching
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
- Interdepartmental Neuroscience Graduate Program, UCLA School of Medicine, Los Angeles, California 90095, USA
| | - Vincent Chouraki
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts,02118, USA
- Framingham Heart Study, 17 Mount Wayte Avenue, Framingham, Massachusetts 01703 USA
- Lille University, Inserm, CHU Lille, Institut Pasteur de Lille, U1167—RID-AGE—Risk factors and molecular determinants of aging-related diseases, F-59000 Lille, France
| | | | - Fabrice Crivello
- IMN UMR5293, GIN, CNRS, CEA, University of Bordeaux, 146 rue Léo Saignat, 33076 Bordeaux, France
| | - Anouk Den Braber
- Biological Psychology, Amsterdam Neuroscience, Vrije Universiteit & Vrije Universiteit Medical Center, 1081 BT Amsterdam, The Netherlands
| | - Nhat Trung Doan
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
| | - Stefan Ehrlich
- Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, 01307 Dresden, Germany
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA
| | - Sudheer Giddaluru
- NORMENT—KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway
- Dr Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, 5021 Bergen, Norway
| | - Aaron L. Goldman
- Lieber Institute for Brain Development, Baltimore, Maryland 21205, USA
| | - Rebecca F. Gottesman
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
| | - Oliver Grimm
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, 68159 Mannheim, Germany
| | - Michael E. Griswold
- Department of Data Science, University of Mississippi Medical Center, Jackson, Mississippi, 39216, USA
| | - Tulio Guadalupe
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, 6525 XD Nijmegen, The Netherlands
- International Max Planck Research School for Language Sciences, 6525 XD Nijmegen, The Netherlands
| | - Boris A. Gutman
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
| | - Johanna Hass
- Department of Child and Adolescent Psychiatry, Faculty of Medicine of the TU Dresden, 01307 Dresden, Germany
| | - Unn K. Haukvik
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
- Department of Research and Development, Diakonhjemmet Hospital, 0319 Oslo, Norway
| | - David Hoehn
- Max Planck Institute of Psychiatry, 80804 Munich, Germany
| | - Avram J. Holmes
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Department of Psychology, Yale University, New Haven, Connecticut 06520, USA
| | - Martine Hoogman
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Deborah Janowitz
- Department of Psychiatry, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Tianye Jia
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK
| | - Kjetil N. Jørgensen
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
- Department of Research and Development, Diakonhjemmet Hospital, 0319 Oslo, Norway
| | | | - Dalia Kasperaviciute
- UCL Institute of Neurology, London, United Kingdom and Epilepsy Society, Bucks, SL9 0RJ, UK
- Department of Medicine, Imperial College London, London SW7 2AZ, UK
| | - Sungeun Kim
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Marieke Klein
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Bernd Kraemer
- Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, 69120, Germany
| | - Phil H. Lee
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Harvard Medical School, Boston, Massachusetts 02115, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Boston, Massachusetts 02141, USA
- Lurie Center for Autism, Massachusetts General Hospital, Harvard Medical School, Lexington, Massachusetts, 02421, USA
| | - David C. M. Liewald
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Lorna M. Lopez
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Michelle Luciano
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Christine Macare
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK
| | - Andre F. Marquand
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, 6525 EN, The Netherlands
| | - Mar Matarin
- UCL Institute of Neurology, London, United Kingdom and Epilepsy Society, Bucks, SL9 0RJ, UK
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
| | - Karen A. Mather
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
| | - Manuel Mattheisen
- Department of Biomedicine, Aarhus University, DK-8000 Aarhus, Denmark
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, DK-8000 Aarhus and Copenhagen, Denmark
- Center for integrated Sequencing, iSEQ, Aarhus University, DK-8000 Aarhus, Denmark
| | - David R. McKay
- Department of Psychiatry, Yale University, New Haven, Connecticut 06511, USA
- Olin Neuropsychiatric Research Center, Hartford, Connecticut 06114, USA
| | - Yuri Milaneschi
- Department of Psychiatry, EMGO Institute for Health and Care Research and Neuroscience Campus Amsterdam, VU University Medical Center/GGZ inGeest, 1081 HL Amsterdam, The Netherlands
| | - Susana Muñoz Maniega
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Kwangsik Nho
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Allison C. Nugent
- Human Genetics Branch, National Institute of Mental Health Intramural Research Program, 35 Convent Drive, Rm 1A202, Bethesda, Maryland 20892-3719, USA
| | - Paul Nyquist
- Department of Neurology, Department of Anesthesia/Critical Care Medicine, Department of Neurosurgery, Johns Hopkins, USA600 N. Wolfe St, Baltimore, Maryland 21287, USA
| | - Loes M. Olde Loohuis
- Center for Neurobehavioral Genetics, University of California, Los Angeles, California 90095, USA
| | - Jaap Oosterlaan
- Department of Clinical Neuropsychology, VU University Amsterdam, Amsterdam, 1081 HV, The Netherlands
| | - Martina Papmeyer
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh EH10 5HF, UK
- Division of Systems Neuroscience of Psychopathology, Translational Research Center, University Hospital of Psychiatry, University of Bern, Bern, 3060, Switzerland
| | - Lukas Pirpamer
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Auenbruggerplatz 22, 8036 Graz, Austria
| | - Benno Pütz
- Max Planck Institute of Psychiatry, 80804 Munich, Germany
| | - Adaikalavan Ramasamy
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
- Department of Medical and Molecular Genetics, King's College London, London SE1 9RT, UK
- The Jenner Institute Laboratories, University of Oxford, Oxford OX3 7DQ, UK
| | - Jennifer S. Richards
- Department of Cognitive Neuroscience, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, 6525 GC, The Netherlands
| | - Shannon L. Risacher
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Roberto Roiz-Santiañez
- Department of Medicine and Psychiatry, University Hospital Marqués de Valdecilla, School of Medicine, University of Cantabria-IDIVAL, 39008 Santander, Spain
- CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Santander, 39011, Spain
| | - Nanda Rommelse
- Department of Psychiatry, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, 6525 GC, The Netherlands
| | - Stefan Ropele
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Auenbruggerplatz 22, 8036 Graz, Austria
| | - Emma J. Rose
- Psychosis Research Group, Department of Psychiatry & Trinity Translational Medicine Institute, Trinity College, Dublin, Dublin 2, Ireland
| | - Natalie A. Royle
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
| | - Tatjana Rundek
- Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- Department of Epidemiology and Public Health Sciences, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
| | | | - Arvin Saremi
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
| | - Claudia L. Satizabal
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts,02118, USA
- Framingham Heart Study, 17 Mount Wayte Avenue, Framingham, Massachusetts 01703 USA
| | - Lianne Schmaal
- Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, Victoria, 3502, Australia
- Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, 3502, Australia
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center, 1007 MB Amsterdam, The Netherlands
| | - Andrew J. Schork
- Multimodal Imaging Laboratory, Department of Neurosciences, University of California, San Diego, California 92093, USA
- Department of Cognitive Sciences, University of California, San Diego, California 92161, USA
| | - Li Shen
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Jean Shin
- Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada M5G 1X8
| | - Elena Shumskaya
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, 6525 EN, The Netherlands
| | - Albert V. Smith
- Icelandic Heart Association, Kopavogur, 201, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, 101, Iceland
| | - Emma Sprooten
- Department of Psychiatry, Yale University, New Haven, Connecticut 06511, USA
- Olin Neuropsychiatric Research Center, Hartford, Connecticut 06114, USA
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, 10029, USA
| | - Lachlan T. Strike
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland 4072, Australia
| | - Alexander Teumer
- Institute for Community Medicine, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Diana Tordesillas-Gutierrez
- CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Santander, 39011, Spain
- Neuroimaging Unit, Technological Facilities. Valdecilla Biomedical Research Institute IDIVAL, Santander, Cantabria, 39011, Spain
| | | | - Daniah Trabzuni
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
- Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia
| | - Stella Trompet
- Department of Cardiology, Leiden University Medical Center, Leiden, 2300RC, The Netherlands
| | - Dhananjay Vaidya
- GeneSTAR Research Center, Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument St Suite 8028, Baltimore, Maryland 21287, USA
| | - Jeroen Van der Grond
- Department of Radiology, Leiden University Medical Center, Leiden, 2300RC, The Netherlands
| | - Sven J. Van der Lee
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
| | - Dennis Van der Meer
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands
| | - Marjolein M. J. Van Donkelaar
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Kristel R. Van Eijk
- Brain Center Rudolf Magnus, Human Neurogenetics Unit, UMC Utrecht, 3584 CG Utrecht, The Netherlands
| | - Theo G. M. Van Erp
- Department of Psychiatry and Human Behavior, University of California-Irvine, Irvine, California 92617, USA
| | - Daan Van Rooij
- Department of Cognitive Neuroscience, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands
| | - Esther Walton
- Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, 01307 Dresden, Germany
- Department of Psychology, Georgia State University, Atlanta, Georgia 30302, USA
| | - Lars T. Westlye
- NORMENT—KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, 0424 Oslo, Norway
- Department of Psychology, Georgia State University, Atlanta, Georgia 30302, USA
| | - Christopher D. Whelan
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
- The Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland
| | - Beverly G. Windham
- NORMENT—KG Jebsen Centre, Department of Psychology, University of Oslo, 0317 Oslo, Norway
| | - Anderson M. Winkler
- Department of Psychiatry, Yale University, New Haven, Connecticut 06511, USA
- Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, 39216, USA
| | - Katharina Wittfeld
- Department of Psychiatry, University Medicine Greifswald, 17489 Greifswald, Germany
- FMRIB Centre, University of Oxford, Oxford OX3 9DU, UK
| | - Girma Woldehawariat
- Human Genetics Branch, National Institute of Mental Health Intramural Research Program, 35 Convent Drive, Rm 1A202, Bethesda, Maryland 20892-3719, USA
| | - Christiane Wolf
- German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, 17487 Greifswald, Germany
| | - Thomas Wolfers
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Lisa R. Yanek
- GeneSTAR Research Center, Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument St Suite 8028, Baltimore, Maryland 21287, USA
| | - Jingyun Yang
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois 60612, USA
- University of Wuerzburg, Department of Psychiatry, Psychosomatics and Psychotherapy, Wuerzburg, 97080, Germany
| | - Alex Zijdenbos
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
| | - Marcel P. Zwiers
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, 6525 EN, The Netherlands
| | - Ingrid Agartz
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
- Department of Research and Development, Diakonhjemmet Hospital, 0319 Oslo, Norway
- Biospective Inc, Montreal, Quebec, Canada, 6100 Avenue Royalmount, Montréal, Québec, Canada H4P 2R2
| | - Laura Almasy
- Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, SE-171 77 Stockholm, Sweden
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine, Brownsville/Edinburg/San Antonio, Texas, 78250, USA
- Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - David Ames
- Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 29104, USA
- National Ageing Research Institute, Royal Melbourne Hospital, Melbourne, Victoria 3052, Australia
| | - Philippe Amouyel
- Lille University, Inserm, CHU Lille, Institut Pasteur de Lille, U1167—RID-AGE—Risk factors and molecular determinants of aging-related diseases, F-59000 Lille, France
| | - Ole A. Andreassen
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
- NORMENT—KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, 0424 Oslo, Norway
| | - Sampath Arepalli
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
| | - Amelia A. Assareh
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
| | - Sandra Barral
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain; G.H. Sergievsky Center; Department of Neurology. Columbia University Medical Center, 639 West 1168th Street, New York, New York 10032, USA
| | - Mark E. Bastin
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
| | - Diane M. Becker
- GeneSTAR Research Center, Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument St Suite 8028, Baltimore, Maryland 21287, USA
| | - James T. Becker
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
| | - David A. Bennett
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois 60612, USA
- University of Wuerzburg, Department of Psychiatry, Psychosomatics and Psychotherapy, Wuerzburg, 97080, Germany
| | - John Blangero
- Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, SE-171 77 Stockholm, Sweden
| | - Hans van Bokhoven
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Dorret I. Boomsma
- Biological Psychology, Amsterdam Neuroscience, Vrije Universiteit & Vrije Universiteit Medical Center, 1081 BT Amsterdam, The Netherlands
| | - Henry Brodaty
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
- Departments of Psychiatry, Neurology, and Psychology, University of Pittsburgh, 3501 Forbes Ave., Suite 830, Pittsburgh, Pennsylvania 15213, USA
| | - Rachel M. Brouwer
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Han G. Brunner
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Dementia Collaborative Research Centre—Assessment and Better Care, University of New South Wales, Sydney, New South Wales 2052, Australia
| | - Randy L. Buckner
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Department of Clinical Genetics and GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 6200 MD Maastricht, The Netherlands
| | - Jan K. Buitelaar
- Department of Cognitive Neuroscience, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, 6525 GC, The Netherlands
| | - Kazima B. Bulayeva
- Department of Psychology, Center for Brain Science, Harvard University, Cambridge, Massachusetts 02138, USA
| | - Wiepke Cahn
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Vince D. Calhoun
- Department of Evolution and Genetics, Dagestan State University, Makhachkala 367000, Dagestan, Russia
- The Mind Research Network & LBERI, Albuquerque, New Mexico 87106, USA
| | - Dara M. Cannon
- Human Genetics Branch, National Institute of Mental Health Intramural Research Program, 35 Convent Drive, Rm 1A202, Bethesda, Maryland 20892-3719, USA
- Department of ECE, University of New Mexico, Albuquerque, New Mexico 87131, USA
| | | | - Ching-Yu Cheng
- Academic Medicine Research Institute, Duke-NUS Graduate Medical School, Singapore, 169857, Singapore
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, 168751, Singapore
- Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, H91 TK33 Galway, Ireland
| | - Sven Cichon
- Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119077, Singapore
- Division of Medical Genetics, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland
- Institute of Human Genetics, University of Bonn, 53127 Bonn, Germany
| | - Mark R. Cookson
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
| | - Aiden Corvin
- Psychosis Research Group, Department of Psychiatry & Trinity Translational Medicine Institute, Trinity College, Dublin, Dublin 2, Ireland
| | - Benedicto Crespo-Facorro
- Department of Medicine and Psychiatry, University Hospital Marqués de Valdecilla, School of Medicine, University of Cantabria-IDIVAL, 39008 Santander, Spain
- CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Santander, 39011, Spain
| | - Joanne E. Curran
- Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, SE-171 77 Stockholm, Sweden
| | - Michael Czisch
- Max Planck Institute of Psychiatry, 80804 Munich, Germany
| | - Anders M. Dale
- Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, 52425 Jülich, Germany
- Center for Multimodal Imaging and Genetics, University of California, San Diego, California 92093, USA
| | - Gareth E. Davies
- Departments of Neurosciences, Radiology, Psychiatry, and Cognitive Science, University of California, San Diego, California 92093, USA
| | | | - Eco J. C. De Geus
- Biological Psychology, Amsterdam Neuroscience, Vrije Universiteit & Vrije Universiteit Medical Center, 1081 BT Amsterdam, The Netherlands
| | - Philip L. De Jager
- Harvard Medical School, Boston, Massachusetts 02115, USA
- Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, 2300RC, The Netherlands
- Program in Translational NeuroPsychiatric Genomics, Departments of Neurology & Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, 02115, USA
- Harvard Medical School, Boston, Massachusetts, 02115, USA
- Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, 02142, USA
| | | | - Ian J. Deary
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
| | - Stéphanie Debette
- INSERM Unit U1219, University of Bordeaux, 33076 Bordeaux, France
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts,02118, USA
- Faculty of Health and Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Brisbane, Queensland 4059, Australia
| | - Charles DeCarli
- Department of Neurology, Bordeaux University Hospital, Bordeaux, 33076, France
| | - Norman Delanty
- The Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland
- Imaging of Dementia and Aging (IDeA) Laboratory, Department of Neurology and Center for Neuroscience, University of California at Davis, 4860 Y Street, Suite 3700, Sacramento, California 95817, USA
| | | | - Anita DeStefano
- Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts 02118 USA
- Framingham Heart Study, 17 Mount Wayte Avenue, Framingham, Massachusetts 01703 USA
| | - Allissa Dillman
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
| | - Srdjan Djurovic
- NORMENT—KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway
- Department of Neurology, Hopital Erasme, Universite Libre de Bruxelles, 1070 Brussels, Belgium
| | - Gary Donohoe
- Department of Medical Genetics, Oslo University Hospital, 0420 Oslo, Norway
- Cognitive Genetics and Cognitive Therapy Group, Neuroimaging, Cognition & Genomics Centre (NICOG) & NCBES Galway Neuroscience Centre, School of Psychology and Discipline of Biochemistry, National University of Ireland Galway, H91 TK33, Galway, Ireland
| | - Wayne C. Drevets
- Human Genetics Branch, National Institute of Mental Health Intramural Research Program, 35 Convent Drive, Rm 1A202, Bethesda, Maryland 20892-3719, USA
- Neuropsychiatric Genetics Research Group, Department of Psychiatry and Trinity College Institute of Psychiatry, Trinity College Dublin, Dublin 8, Ireland
| | - Ravi Duggirala
- Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, SE-171 77 Stockholm, Sweden
| | - Thomas D. Dyer
- Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, SE-171 77 Stockholm, Sweden
| | - Christian Enzinger
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Auenbruggerplatz 22, 8036 Graz, Austria
| | - Susanne Erk
- Janssen Research & Development, LLC, Titusville, New Jersey 08560, USA
| | - Thomas Espeseth
- NORMENT—KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, 0424 Oslo, Norway
- Department of Psychology, Georgia State University, Atlanta, Georgia 30302, USA
| | - Iryna O. Fedko
- Biological Psychology, Amsterdam Neuroscience, Vrije Universiteit & Vrije Universiteit Medical Center, 1081 BT Amsterdam, The Netherlands
| | - Guillén Fernández
- Department of Cognitive Neuroscience, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Luigi Ferrucci
- Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Department of Psychiatry and Psychotherapy, Charitéplatz 1, 10117 Berlin, Germany
| | - Simon E. Fisher
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, 6525 XD Nijmegen, The Netherlands
| | - Debra A. Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois 60612, USA
- Intramural Research Program of the National Institute on Aging, Baltimore, Maryland, 21224, USA
| | - Ian Ford
- Department of Neurological Sciences & Department of Behavioral Sciences, Rush University Medical Center, Chicago, Illinois 60616, USA
| | - Myriam Fornage
- Robertson Centre for Biostatistics, University of Glasgow, Glasgow, G41 4DQ, UK
| | - Tatiana M. Foroud
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Institute of Molecular Medicine and Human Genetics Center, University of Texas Health Science Center at Houston, Houston, Texas, 77030, USA
| | - Peter T. Fox
- Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Clyde Francks
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, 6525 XD Nijmegen, The Netherlands
| | - Masaki Fukunaga
- University of Texas Health Science Center, San Antonio, Texas 78229, USA
| | - J. Raphael Gibbs
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
| | - David C. Glahn
- Department of Psychiatry, Yale University, New Haven, Connecticut 06511, USA
- Olin Neuropsychiatric Research Center, Hartford, Connecticut 06114, USA
| | - Randy L. Gollub
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA
- Harvard Medical School, Boston, Massachusetts 02115, USA
| | - Harald H. H. Göring
- Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, SE-171 77 Stockholm, Sweden
| | - Robert C. Green
- Harvard Medical School, Boston, Massachusetts 02115, USA
- Division of Cerebral Integration, National Institute for Physiological Sciences, Aichi, 444-8585, Japan
| | - Oliver Gruber
- Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, 69120, Germany
| | - Vilmundur Gudnason
- Icelandic Heart Association, Kopavogur, 201, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, 101, Iceland
| | - Sebastian Guelfi
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
| | - Asta K. Håberg
- Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA
- Department of Neuroscience, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, 7491, Norway
| | - Narelle K. Hansell
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland 4072, Australia
| | - John Hardy
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
| | - Catharina A. Hartman
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands
| | - Ryota Hashimoto
- Department of Radiology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, 7030, Norway
- Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan
| | - Katrin Hegenscheid
- Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, 565-0871, Japan
| | - Andreas Heinz
- Janssen Research & Development, LLC, Titusville, New Jersey 08560, USA
| | - Stephanie Le Hellard
- NORMENT—KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway
- Dr Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, 5021 Bergen, Norway
| | - Dena G. Hernandez
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
- Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Dirk J. Heslenfeld
- German Center for Neurodegenerative Diseases (DZNE), Tübingen, 72076, Germany
| | - Beng-Choon Ho
- Department of Psychology, VU University Amsterdam, 1081 BT Amsterdam, The Netherlands
| | - Pieter J. Hoekstra
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, 9700RB, The Netherlands
| | - Wolfgang Hoffmann
- Institute for Community Medicine, University Medicine Greifswald, 17489 Greifswald, Germany
- FMRIB Centre, University of Oxford, Oxford OX3 9DU, UK
| | - Albert Hofman
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115 USA
| | - Florian Holsboer
- Max Planck Institute of Psychiatry, 80804 Munich, Germany
- Department of Psychiatry, University of Iowa, Iowa City, Iowa 52242, USA
| | - Georg Homuth
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115 USA
| | - Norbert Hosten
- Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, 565-0871, Japan
| | - Jouke-Jan Hottenga
- Biological Psychology, Amsterdam Neuroscience, Vrije Universiteit & Vrije Universiteit Medical Center, 1081 BT Amsterdam, The Netherlands
| | | | - Hilleke E. Hulshoff Pol
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Masashi Ikeda
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Clifford R. Jack Jr
- Translational Genomics Research Institute, Neurogenomics Division, 445N Fifth Street, Phoenix, Arizona 85004, USA
| | - Mark Jenkinson
- Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, 39216, USA
| | - Robert Johnson
- Department of Psychiatry, Fujita Health University School of Medicine, Toyoake 470-1192, Japan
| | - Erik G. Jönsson
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
- Biospective Inc, Montreal, Quebec, Canada, 6100 Avenue Royalmount, Montréal, Québec, Canada H4P 2R2
| | - J. Wouter Jukema
- Department of Cardiology, Leiden University Medical Center, Leiden, 2300RC, The Netherlands
| | - René S. Kahn
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Ryota Kanai
- Department of Radiology, Mayo Clinic, Rochester, Minnesota 55905, USA
- NICHD Brain and Tissue Bank for Developmental Disorders, University of Maryland Medical School, Baltimore, Maryland 21201, USA
- School of Psychology, University of Sussex, Brighton BN1 9QH, UK
| | - Iwona Kloszewska
- Institute of Cognitive Neuroscience, University College London, London WC1N 3AR, UK
| | - David S. Knopman
- Department of Neuroinformatics, Araya Brain Imaging, Tokyo, 102-0093, Japan
| | | | - John B. Kwok
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, 55905, USA
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, 21228, USA
| | - Stephen M. Lawrie
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh EH10 5HF, UK
| | - Hervé Lemaître
- Neuroscience Research Australia, Sydney, New South Wales 2031, Australia
| | - Xinmin Liu
- Human Genetics Branch, National Institute of Mental Health Intramural Research Program, 35 Convent Drive, Rm 1A202, Bethesda, Maryland 20892-3719, USA
- School of Medical Sciences, UNSW, Sydney, New South Wales 2052, Australia
| | - Dan L. Longo
- INSERM UMR 1000 “Neuroimaging and Psychiatry”, Service Hospitalier Frédéric Joliot; University Paris-Sud, Université Paris-Saclay, University Paris Descartes, Maison de Solenn, Paris, 91400, France
| | - Oscar L. Lopez
- Columbia University Medical Center, New York, New York 10032, USA
| | - Simon Lovestone
- Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA
- Departments of Neurology and Psychiatry, University of Pittsburgh, 3501 Forbes Ave., Suite 830, Pittsburgh Pennsylvania 15213, USA
| | - Oliver Martinez
- Department of Neurology, Bordeaux University Hospital, Bordeaux, 33076, France
| | - Jean-Luc Martinot
- Neuroscience Research Australia, Sydney, New South Wales 2031, Australia
| | - Venkata S. Mattay
- Lieber Institute for Brain Development, Baltimore, Maryland 21205, USA
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
- Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK
| | - Colm McDonald
- Department of ECE, University of New Mexico, Albuquerque, New Mexico 87131, USA
| | - Andrew M. McIntosh
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh EH10 5HF, UK
| | - Francis J. McMahon
- Human Genetics Branch, National Institute of Mental Health Intramural Research Program, 35 Convent Drive, Rm 1A202, Bethesda, Maryland 20892-3719, USA
| | - Katie L. McMahon
- Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
| | - Patrizia Mecocci
- Centre for Advanced Imaging, University of Queensland, Brisbane, Queensland 4072, Australia
| | - Ingrid Melle
- NORMENT—KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway
- NORMENT—KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, 0424 Oslo, Norway
| | - Andreas Meyer-Lindenberg
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, 68159 Mannheim, Germany
| | - Sebastian Mohnke
- Janssen Research & Development, LLC, Titusville, New Jersey 08560, USA
| | - Grant W. Montgomery
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia
| | - Derek W. Morris
- Department of Medical Genetics, Oslo University Hospital, 0420 Oslo, Norway
| | - Thomas H. Mosley
- NORMENT—KG Jebsen Centre, Department of Psychology, University of Oslo, 0317 Oslo, Norway
| | - Thomas W. Mühleisen
- Division of Medical Genetics, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland
- Institute of Human Genetics, University of Bonn, 53127 Bonn, Germany
| | - Bertram Müller-Myhsok
- Max Planck Institute of Psychiatry, 80804 Munich, Germany
- Section of Gerontology and Geriatrics, Department of Medicine, University of Perugia, 06132 Perugia, Italy
- Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany
| | - Michael A. Nalls
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
| | - Matthias Nauck
- University of Liverpool, Institute of Translational Medicine, Liverpool L69 3BX, UK
- Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Thomas E. Nichols
- Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, 39216, USA
- German Center for Cardiovascular Research (DZHK e.V.), partner site Greifswald, Greifswald, 17475, Germany
| | - Wiro J. Niessen
- Department of Radiology and Nuclear Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands
- Department of Statistics & WMG, University of Warwick, Coventry CV4 7AL, UK
- Department of Medical Informatics Erasmus MC, 3015 CE Rotterdam, The Netherlands
| | - Markus M. Nöthen
- Division of Medical Genetics, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland
- Faculty of Applied Sciences, Delft University of Technology, Delft, 2628 CD, The Netherlands
| | - Lars Nyberg
- Department of Integrative Medical Biology and Umeå Center for Functional Brain Imaging, Umeå University, 901 87 Umeå, Sweden
| | - Kazutaka Ohi
- Department of Radiology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, 7030, Norway
| | - Rene L. Olvera
- Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
| | - Roel A. Ophoff
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
- Center for Neurobehavioral Genetics, University of California, Los Angeles, California 90095, USA
| | | | - Tomas Paus
- Department of Genomics, Life & Brain Center, University of Bonn, 53127 Bonn, Germany
- Rotman Research Institute, University of Toronto, Toronto, Ontario, Canada M6A 2E1
- Departments of Psychology and Psychiatry, University of Toronto, Toronto, Ontario, Canada M5T 1R8
| | - Zdenka Pausova
- Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada M5G 1X8
- Child Mind Institute, New York, New York, 10022, USA
| | - Brenda W. J. H. Penninx
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center, 1007 MB Amsterdam, The Netherlands
| | - G. Bruce Pike
- Departments of Physiology and Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada M5S 3E2
- Department of Radiology, University of Calgary, Calgary, Alberta, Canada T2N 4N1
| | - Steven G. Potkin
- Department of Psychiatry and Human Behavior, University of California-Irvine, Irvine, California 92617, USA
| | - Bruce M. Psaty
- Department of Clinical Neuroscience, University of Calgary, Calgary, Alberta, Canada T2N 4N1
| | - Simone Reppermund
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
- Departments of Epidemiology, Medicine and Health Services, University of Washington, Seattle, WA, USA Group Health Research Institute, Group Health, 1730 Minor Avenue/Suite 1360, Seattle, Washington 98101, USA
| | - Marcella Rietschel
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, 68159 Mannheim, Germany
| | - Joshua L. Roffman
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
| | | | - Jerome I. Rotter
- Department of Developmental Disability Neuropsychiatry, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
| | - Mina Ryten
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK
- Department of Medical and Molecular Genetics, King's College London, London SE1 9RT, UK
| | - Ralph L. Sacco
- John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- Department of Epidemiology and Public Health Sciences, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- Institute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute and Pediatrics at Harbor-UCLA Medical Center, Torrance, California 90502, USA
| | - Perminder S. Sachdev
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
- Evelyn F. McKnight Brain Institute, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
| | - Andrew J. Saykin
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
- Institute of Molecular Medicine and Human Genetics Center, University of Texas Health Science Center at Houston, Houston, Texas, 77030, USA
| | - Reinhold Schmidt
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Auenbruggerplatz 22, 8036 Graz, Austria
| | - Helena Schmidt
- Neuropsychiatric Institute, Prince of Wales Hospital, Randwick, New South Wales 2031, Australia
| | - Peter R. Schofield
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, 55905, USA
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, 21228, USA
| | | | - Andrew Simmons
- Institute of Molecular Biology and Biochemistry, Medical University Graz, Harrachgasse 21/III, 8010 Graz, Austria
- Department of Neuroimaging, Institute of Psychiatry, King's College London, London SE5 8AF, UK
- Biomedical Research Centre for Mental Health, King's College London, London SE5 8AF, UK
| | - Andrew Singleton
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
| | - Sanjay M. Sisodiya
- UCL Institute of Neurology, London, United Kingdom and Epilepsy Society, Bucks, SL9 0RJ, UK
| | - Colin Smith
- Biomedical Research Unit for Dementia, King's College London, London SE5 8AF, UK
| | - Jordan W. Smoller
- Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
- Harvard Medical School, Boston, Massachusetts 02115, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Boston, Massachusetts 02141, USA
| | - Hilkka Soininen
- MRC Edinburgh Brain Bank, University of Edinburgh, Academic Department of Neuropathology, Centre for Clinical Brain Sciences, Edinburgh, EH16 4SB UK
- Institute of Clinical Medicine, Neurology, University of Eastern Finland, FI-70211 Kuopio, Finland
| | - Vidar M. Steen
- NORMENT—KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, 5021 Bergen, Norway
- Dr Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, 5021 Bergen, Norway
| | - David J. Stott
- Neurocentre Neurology, Kuopio University Hospital, FI-70211 Kuopio, Finland
| | - Jessika E. Sussmann
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh EH10 5HF, UK
| | - Anbupalam Thalamuthu
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
| | - Arthur W. Toga
- Institute of Cardiovascular and Medical Sciences, Faculty of Medicine, University of Glasgow, Glasgow, G4 0SF, UK
| | - Bryan J. Traynor
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria 3101, Australia
| | - Juan Troncoso
- Laboratory of Neuro Imaging, Institute for Neuroimaging and Informatics, Keck School of Medicine of the University of Southern California, Los Angeles, California 90033, USA
| | - Magda Tsolaki
- Department of Pathology, Johns Hopkins University, Baltimore, Maryland 21205, USA
| | - Christophe Tzourio
- INSERM Unit U1219, University of Bordeaux, 33076 Bordeaux, France
- 3rd Department of Neurology, "G. Papanicolaou", Hospital, Aristotle University of Thessaloniki, Thessaloniki, 57010, Greece
| | - Andre G. Uitterlinden
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
- Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR1219, Bordeaux, F-33000, France
| | - Maria C. Valdés Hernández
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
| | - Marcel Van der Brug
- Department of Internal Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands
| | - Aad van der Lugt
- Department of Radiology and Nuclear Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands
| | | | - Neeltje E. M. Van Haren
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, 3584 CX Utrecht, The Netherlands
| | - Dennis van 't Ent
- Biological Psychology, Amsterdam Neuroscience, Vrije Universiteit & Vrije Universiteit Medical Center, 1081 BT Amsterdam, The Netherlands
| | - Marie-Jose Van Tol
- Department of Psychiatry and Leiden Institute for Brain and Cognition, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
| | - Badri N. Vardarajan
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain; G.H. Sergievsky Center; Department of Neurology. Columbia University Medical Center, 639 West 1168th Street, New York, New York 10032, USA
| | - Bruno Vellas
- University of Groningen, University Medical Center Groningen, Department of Neuroscience, 9713 AW Groningen, the Netherlands
| | - Dick J. Veltman
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center, 1007 MB Amsterdam, The Netherlands
| | - Henry Völzke
- Institute for Community Medicine, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Henrik Walter
- Janssen Research & Development, LLC, Titusville, New Jersey 08560, USA
| | - Joanna M. Wardlaw
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh EH4 2XU, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh EH8 9JZ, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH16 4SB, UK
| | - Thomas H. Wassink
- Department of Internal Medicine and Geriatric Medicine, INSERM U1027, University of Toulouse, Toulouse, 31024, France
| | - Michael E. Weale
- Department of Medical and Molecular Genetics, King's College London, London SE1 9RT, UK
| | - Daniel R. Weinberger
- Lieber Institute for Brain Development, Baltimore, Maryland 21205, USA
- Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USA
| | - Michael W. Weiner
- Departments of Psychiatry, Neurology, Neuroscience and the Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
| | - Wei Wen
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, New South Wales 2052, Australia
- Evelyn F. McKnight Brain Institute, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
| | - Eric Westman
- Center for Imaging of Neurodegenerative Disease, San Francisco VA Medical Center, University of California, San Francisco, California 94121, USA
| | - Tonya White
- Department of Radiology and Nuclear Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, SE-141 57 Huddinge, Sweden
| | - Tien Y. Wong
- Academic Medicine Research Institute, Duke-NUS Graduate Medical School, Singapore, 169857, Singapore
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, 168751, Singapore
- Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, H91 TK33 Galway, Ireland
| | - Clinton B. Wright
- Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- Department of Epidemiology and Public Health Sciences, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- Institute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute and Pediatrics at Harbor-UCLA Medical Center, Torrance, California 90502, USA
| | - Ronald H. Zielke
- Department of Psychiatry, Fujita Health University School of Medicine, Toyoake 470-1192, Japan
| | - Alan B. Zonderman
- Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC-Sophia Children's Hospital, 3015 CE Rotterdam, The Netherlands
| | - Nicholas G. Martin
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia
| | - Cornelia M. Van Duijn
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
| | - Margaret J. Wright
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland 4072, Australia
- Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
| | - W. T. Longstreth
- Laboratory of Epidemiology & Population Sciences, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
| | - Gunter Schumann
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK
| | - Hans J. Grabe
- Department of Psychiatry, University Medicine Greifswald, 17489 Greifswald, Germany
| | - Barbara Franke
- Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Department of Psychiatry, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, 6525 GA Nijmegen, The Netherlands
| | - Lenore J. Launer
- Departments of Neurology and Epidemiology, University of Washington, 325 Ninth Avenue, Seattle, Washington 98104-2420, USA
| | - Sarah E. Medland
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia
| | - Sudha Seshadri
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts,02118, USA
- Framingham Heart Study, 17 Mount Wayte Avenue, Framingham, Massachusetts 01703 USA
| | - Paul M. Thompson
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California 90292, USA
| | - M. Arfan Ikram
- Department of Epidemiology, Erasmus University Medical Center, 3015 CE Rotterdam, The Netherlands
- Department of Radiology and Nuclear Medicine, Erasmus MC, 3015 CE Rotterdam, The Netherlands
- Intramural Research Program, NIA, NIH, 7201 Wisconsin Ave, Suite 3C-309, Bethesda, Maryland 20892, USA
| |
Collapse
|
22
|
Adams HHH, Hibar DP, Chouraki V, Stein JL, Nyquist PA, Rentería ME, Trompet S, Arias-Vasquez A, Seshadri S, Desrivières S, Beecham AH, Jahanshad N, Wittfeld K, Van der Lee SJ, Abramovic L, Alhusaini S, Amin N, Andersson M, Arfanakis K, Aribisala BS, Armstrong NJ, Athanasiu L, Axelsson T, Beiser A, Bernard M, Bis JC, Blanken LME, Blanton SH, Bohlken MM, Boks MP, Bralten J, Brickman AM, Carmichael O, Chakravarty MM, Chauhan G, Chen Q, Ching CRK, Cuellar-Partida G, Braber AD, Doan NT, Ehrlich S, Filippi I, Ge T, Giddaluru S, Goldman AL, Gottesman RF, Greven CU, Grimm O, Griswold ME, Guadalupe T, Hass J, Haukvik UK, Hilal S, Hofer E, Hoehn D, Holmes AJ, Hoogman M, Janowitz D, Jia T, Kasperaviciute D, Kim S, Klein M, Kraemer B, Lee PH, Liao J, Liewald DCM, Lopez LM, Luciano M, Macare C, Marquand A, Matarin M, Mather KA, Mattheisen M, Mazoyer B, McKay DR, McWhirter R, Milaneschi Y, Mirza-Schreiber N, Muetzel RL, Maniega SM, Nho K, Nugent AC, Loohuis LMO, Oosterlaan J, Papmeyer M, Pappa I, Pirpamer L, Pudas S, Pütz B, Rajan KB, Ramasamy A, Richards JS, Risacher SL, Roiz-Santiañez R, Rommelse N, Rose EJ, Royle NA, Rundek T, Sämann PG, Satizabal CL, Schmaal L, Schork AJ, Shen L, Shin J, Shumskaya E, Smith AV, Sprooten E, Strike LT, Teumer A, Thomson R, Tordesillas-Gutierrez D, Toro R, Trabzuni D, Vaidya D, Van der Grond J, Van der Meer D, Van Donkelaar MMJ, Van Eijk KR, Van Erp TGM, Van Rooij D, Walton E, Westlye LT, Whelan CD, Windham BG, Winkler AM, Woldehawariat G, Wolf C, Wolfers T, Xu B, Yanek LR, Yang J, Zijdenbos A, Zwiers MP, Agartz I, Aggarwal NT, Almasy L, Ames D, Amouyel P, Andreassen OA, Arepalli S, Assareh AA, Barral S, Bastin ME, Becker DM, Becker JT, Bennett DA, Blangero J, van Bokhoven H, Boomsma DI, Brodaty H, Brouwer RM, Brunner HG, Buckner RL, Buitelaar JK, Bulayeva KB, Cahn W, Calhoun VD, Cannon DM, Cavalleri GL, Chen C, Cheng CY, Cichon S, Cookson MR, Corvin A, Crespo-Facorro B, Curran JE, Czisch M, Dale AM, Davies GE, De Geus EJC, De Jager PL, de Zubicaray GI, Delanty N, Depondt C, DeStefano AL, Dillman A, Djurovic S, Donohoe G, Drevets WC, Duggirala R, Dyer TD, Erk S, Espeseth T, Evans DA, Fedko IO, Fernández G, Ferrucci L, Fisher SE, Fleischman DA, Ford I, Foroud TM, Fox PT, Francks C, Fukunaga M, Gibbs JR, Glahn DC, Gollub RL, Göring HHH, Grabe HJ, Green RC, Gruber O, Gudnason V, Guelfi S, Hansell NK, Hardy J, Hartman CA, Hashimoto R, Hegenscheid K, Heinz A, Le Hellard S, Hernandez DG, Heslenfeld DJ, Ho BC, Hoekstra PJ, Hoffmann W, Hofman A, Holsboer F, Homuth G, Hosten N, Hottenga JJ, Hulshoff Pol HE, Ikeda M, Ikram MK, Jack CR, Jenkinson M, Johnson R, Jönsson EG, Jukema JW, Kahn RS, Kanai R, Kloszewska I, Knopman DS, Kochunov P, Kwok JB, Lawrie SM, Lemaître H, Liu X, Longo DL, Longstreth WT, Lopez OL, Lovestone S, Martinez O, Martinot JL, Mattay VS, McDonald C, McIntosh AM, McMahon KL, McMahon FJ, Mecocci P, Melle I, Meyer-Lindenberg A, Mohnke S, Montgomery GW, Morris DW, Mosley TH, Mühleisen TW, Müller-Myhsok B, Nalls MA, Nauck M, Nichols TE, Niessen WJ, Nöthen MM, Nyberg L, Ohi K, Olvera RL, Ophoff RA, Pandolfo M, Paus T, Pausova Z, Penninx BWJH, Pike GB, Potkin SG, Psaty BM, Reppermund S, Rietschel M, Roffman JL, Romanczuk-Seiferth N, Rotter JI, Ryten M, Sacco RL, Sachdev PS, Saykin AJ, Schmidt R, Schofield PR, Sigurdsson S, Simmons A, Singleton A, Sisodiya SM, Smith C, Smoller JW, Soininen H, Srikanth V, Steen VM, Stott DJ, Sussmann JE, Thalamuthu A, Tiemeier H, Toga AW, Traynor BJ, Troncoso J, Turner JA, Tzourio C, Uitterlinden AG, Hernández MCV, Van der Brug M, Van der Lugt A, Van der Wee NJA, Van Duijn CM, Van Haren NEM, Van T Ent D, Van Tol MJ, Vardarajan BN, Veltman DJ, Vernooij MW, Völzke H, Walter H, Wardlaw JM, Wassink TH, Weale ME, Weinberger DR, Weiner MW, Wen W, Westman E, White T, Wong TY, Wright CB, Zielke HR, Zonderman AB, Deary IJ, DeCarli C, Schmidt H, Martin NG, De Craen AJM, Wright MJ, Launer LJ, Schumann G, Fornage M, Franke B, Debette S, Medland SE, Ikram MA, Thompson PM. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat Neurosci 2016; 19:1569-1582. [PMID: 27694991 PMCID: PMC5227112 DOI: 10.1038/nn.4398] [Citation(s) in RCA: 149] [Impact Index Per Article: 18.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2016] [Accepted: 08/31/2016] [Indexed: 02/08/2023]
Abstract
Intracranial volume reflects the maximally attained brain size during development, and remains stable with loss of tissue in late life. It is highly heritable, but the underlying genes remain largely undetermined. In a genome-wide association study of 32,438 adults, we discovered five previously unknown loci for intracranial volume and confirmed two known signals. Four of the loci were also associated with adult human stature, but these remained associated with intracranial volume after adjusting for height. We found a high genetic correlation with child head circumference (ρgenetic = 0.748), which indicates a similar genetic background and allowed us to identify four additional loci through meta-analysis (Ncombined = 37,345). Variants for intracranial volume were also related to childhood and adult cognitive function, and Parkinson's disease, and were enriched near genes involved in growth pathways, including PI3K-AKT signaling. These findings identify the biological underpinnings of intracranial volume and their link to physiological and pathological traits.
Collapse
Affiliation(s)
- Hieab H H Adams
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
- Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands
| | - Derrek P Hibar
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California, USA
| | - Vincent Chouraki
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
- Lille University, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk factors and molecular determinants of aging-related diseases, Lille, France
- Framingham Heart Study, Framingham, Massachusetts, USA
| | - Jason L Stein
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California, USA
- Department of Genetics and UNC Neuroscience Center, University of North Carolina (UNC), Chapel Hill, North Carolina, USA
| | - Paul A Nyquist
- Department of Neurology, Department of Anesthesia/Critical Care Medicine, Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, USA
| | | | - Stella Trompet
- Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
| | - Alejandro Arias-Vasquez
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands
- Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Sudha Seshadri
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
- Framingham Heart Study, Framingham, Massachusetts, USA
| | - Sylvane Desrivières
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Ashley H Beecham
- Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida, USA
- John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA
| | - Neda Jahanshad
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California, USA
| | - Katharina Wittfeld
- German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Greifswald, Germany
- Department of Psychiatry, University Medicine Greifswald, Greifswald, Germany
| | | | - Lucija Abramovic
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Saud Alhusaini
- Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Canada
- The Royal College of Surgeons in Ireland, Dublin 2, Ireland
| | - Najaf Amin
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
| | - Micael Andersson
- Department of Integrative Medical Biology and Umeå center for Functional Brain Imaging, Umeå University, Umeå, Sweden
| | - Konstantinos Arfanakis
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois, USA
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA
- Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, Illinois, USA
| | - Benjamin S Aribisala
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh, UK
- Department of Computer Science, Lagos State University, Lagos, Nigeria
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
| | - Nicola J Armstrong
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
- Mathematics and Statistics, Murdoch University, Perth, Australia
| | - Lavinia Athanasiu
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
| | - Tomas Axelsson
- Department of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
| | - Alexa Beiser
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
- Framingham Heart Study, Framingham, Massachusetts, USA
- Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA
| | - Manon Bernard
- Hospital for Sick Children, University of Toronto, Toronto, Canada
| | - Joshua C Bis
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA
| | - Laura M E Blanken
- Generation R Study Group, Erasmus Medical Center, Rotterdam, the Netherlands
- Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Susan H Blanton
- Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, Florida, USA
- John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA
| | - Marc M Bohlken
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Marco P Boks
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Janita Bralten
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Adam M Brickman
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA
- G.H. Sergievsky Center, Columbia University Medical Center, New York, New York, USA
- Department of Neurology, Columbia University Medical Center, New York, New York, USA
| | - Owen Carmichael
- Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA
| | - M Mallar Chakravarty
- Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal, Canada
- Department of Psychiatry and Biomedical Engineering, McGill University, Montreal, Canada
| | | | - Qiang Chen
- Lieber Institute for Brain Development, Baltimore, Maryland, USA
| | - Christopher R K Ching
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California, USA
- Interdepartmental Neuroscience Graduate Program, UCLA School of Medicine, Los Angeles, California, USA
| | | | - Anouk Den Braber
- Biological Psychology, Neuroscience Campus Amsterdam, Vrije Universiteit University and Vrije Universiteit Medical Center, Amsterdam, the Netherlands
| | - Nhat Trung Doan
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Stefan Ehrlich
- Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, Germany
- Department of Psychiatry, Massachusetts General Hospital, Boston, Masschusetts, USA
- Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, North Carolina, USA
| | - Irina Filippi
- NSERM Unit 1000 ″Neuroimaging and Psychiatry″, University Paris Sud, University Paris Descartes, Paris, France
- Maison de Solenn, Adolescent Psychopathology and Medicine Department, APHP Hospital Cochin, Paris, France
| | - Tian Ge
- Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, North Carolina, USA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA
- Harvard Medical School, Boston, Massachusetts, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Boston, Massachusetts, USA
| | - Sudheer Giddaluru
- NORMENT - KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, Norway
- Dr. Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
| | - Aaron L Goldman
- Lieber Institute for Brain Development, Baltimore, Maryland, USA
| | - Rebecca F Gottesman
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Corina U Greven
- Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, the Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, the Netherlands
- King's College London, Medical Research Council Social, Genetic and Developmental Psychiatry Centre, Institute of Psychology, Psychiatry and Neurosciene, London, UK
| | - Oliver Grimm
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany
| | - Michael E Griswold
- Center of Biostatistics and Bioinformatics, University of Mississippi Medical Center, Jackson, Mississippi, USA
| | - Tulio Guadalupe
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, the Netherlands
- International Max Planck Research School for Language Sciences, Nijmegen, the Netherlands
| | - Johanna Hass
- Department of Child and Adolescent Psychiatry, Faculty of Medicine of the TU Dresden, Dresden, Germany
| | - Unn K Haukvik
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Department of Research and Development, Diakonhjemmet Hospital, Oslo, Norway
| | - Saima Hilal
- Department of Pharmacology, National University of Singapore, Singapore
- Memory Aging and Cognition Centre (MACC), National University Health System, Singapore
| | - Edith Hofer
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Austria, Graz, Austria
- Institute of Medical Informatics, Statistics and Documentation, Medical University Graz, Austria, Graz, Austria
| | - David Hoehn
- Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany
| | - Avram J Holmes
- Department of Psychiatry, Massachusetts General Hospital, Boston, Masschusetts, USA
- Department of Psychology, Yale University, New Haven, Connecticut, USA
| | - Martine Hoogman
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Deborah Janowitz
- Department of Psychiatry, University Medicine Greifswald, Greifswald, Germany
| | - Tianye Jia
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Dalia Kasperaviciute
- UCL Institute of Neurology, London, United Kingdom and Epilepsy Society, Bucks, UK
- Department of Medicine, Imperial College London, London, UK
| | - Sungeun Kim
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Marieke Klein
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Bernd Kraemer
- Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Germany
| | - Phil H Lee
- Department of Psychiatry, Massachusetts General Hospital, Boston, Masschusetts, USA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA
- Harvard Medical School, Boston, Massachusetts, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Boston, Massachusetts, USA
- Lurie Center for Autism, Massachusetts General Hospital, Harvard Medical School, Lexington, Massachusetts, USA
| | - Jiemin Liao
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore
| | - David C M Liewald
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
| | - Lorna M Lopez
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
| | - Michelle Luciano
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
| | - Christine Macare
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Andre Marquand
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, The Netherlands
| | - Mar Matarin
- UCL Institute of Neurology, London, United Kingdom and Epilepsy Society, Bucks, UK
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
| | - Karen A Mather
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
| | - Manuel Mattheisen
- Department of Biomedicine, Aarhus University, Aarhus, Denmark
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus and Copenhagen, Denmark
- Center for integrated Sequencing, iSEQ, Aarhus University, Aarhus, Denmark
| | | | - David R McKay
- Department of Psychiatry, Yale University, New Haven, Connecticut, USA
- Olin Neuropsychiatric Research Center, Hartford, Connecticut, USA
| | - Rebekah McWhirter
- Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia
| | - Yuri Milaneschi
- Department of Psychiatry, EMGO Institute for Health and Care Research and Neuroscience Campus Amsterdam, VU University Medical Center/GGZ inGeest, Amsterdam, The Netherlands
| | - Nazanin Mirza-Schreiber
- Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany
| | - Ryan L Muetzel
- Generation R Study Group, Erasmus Medical Center, Rotterdam, the Netherlands
- Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Susana Muñoz Maniega
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
| | - Kwangsik Nho
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Allison C Nugent
- Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA
| | - Loes M Olde Loohuis
- Center for Neurobehavioral Genetics, University of California, Los Angeles, California, USA
| | - Jaap Oosterlaan
- Department of Clinical Neuropsychology, VU University Amsterdam, Amsterdam, the Netherlands
| | - Martina Papmeyer
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
- Division of Systems Neuroscience of Psychopathology, Translational Research Center, University Hospital of Psychiatry, University of Bern, Switzerland
| | - Irene Pappa
- Generation R Study Group, Erasmus Medical Center, Rotterdam, the Netherlands
- School of Pedagogical and Educational Sciences, Erasmus University Rotterdam, Rotterdam, the Netherlands
| | - Lukas Pirpamer
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Austria, Graz, Austria
| | - Sara Pudas
- Department of Integrative Medical Biology and Umeå center for Functional Brain Imaging, Umeå University, Umeå, Sweden
| | - Benno Pütz
- Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany
| | - Kumar B Rajan
- Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois, USA
| | - Adaikalavan Ramasamy
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
- Department of Medical and Molecular Genetics, King's College London, London, UK
- The Jenner Institute Laboratories, University of Oxford, Oxford, UK
| | - Jennifer S Richards
- Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, the Netherlands
| | - Shannon L Risacher
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Roberto Roiz-Santiañez
- Department of Medicine and Psychiatry, University Hospital Marqués de Valdecilla, School of Medicine, University of Cantabria-IDIVAL, Santander, Spain
- CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Santander, Spain
| | - Nanda Rommelse
- Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, the Netherlands
| | - Emma J Rose
- Psychosis Research Group, Department of Psychiatry and Trinity Translational Medicine Institute, Trinity College Dublin
| | - Natalie A Royle
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
| | - Tatjana Rundek
- Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida, USA
- Department of Epidemiology and Public Health Sciences, University of Miami, Miller School of Medicine, Miami, Florida, USA
| | - Philipp G Sämann
- Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany
| | - Claudia L Satizabal
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
- Framingham Heart Study, Framingham, Massachusetts, USA
| | - Lianne Schmaal
- Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia
- Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands
| | - Andrew J Schork
- Multimodal Imaging Laboratory, Department of Neurosciences, University of California, San Diego, USA
- Department of Cognitive Sciences, University of California, San Diego, USA
| | - Li Shen
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Jean Shin
- Hospital for Sick Children, University of Toronto, Toronto, Canada
| | - Elena Shumskaya
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, The Netherlands
| | - Albert V Smith
- Icelandic Heart Association, Kopavogur, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - Emma Sprooten
- Department of Psychiatry, Yale University, New Haven, Connecticut, USA
- Olin Neuropsychiatric Research Center, Hartford, Connecticut, USA
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Lachlan T Strike
- QIMR Berghofer Medical Research Institute, Brisbane, Australia
- Queensland Brain Institute, University of Queensland, Brisbane, Australia
| | - Alexander Teumer
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Russell Thomson
- School of Computing Engineering and Mathematics, Western Sydney University, Parramatta, Australia
| | - Diana Tordesillas-Gutierrez
- CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Santander, Spain
- Neuroimaging Unit,Technological Facilities. Valdecilla Biomedical Research Institute IDIVAL, Santander, Cantabria, Spain
| | | | - Daniah Trabzuni
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
- Department of Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
| | - Dhananjay Vaidya
- GeneSTAR Research Center, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Jeroen Van der Grond
- Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands
| | - Dennis Van der Meer
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Marjolein M J Van Donkelaar
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Kristel R Van Eijk
- Brain Center Rudolf Magnus, Human Neurogenetics Unit, UMC Utrecht, Utrecht, the Netherlands
| | - Theo G M Van Erp
- Department of Psychiatry and Human Behavior, University of California-Irvine, Irvine, California, USA
| | - Daan Van Rooij
- Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Esther Walton
- Department of Child and Adolescent Psychiatry, Faculty of Medicine of the TU Dresden, Dresden, Germany
| | - Lars T Westlye
- NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
- NORMENT - KG Jebsen Centre, Department of Psychology, University of Oslo, Oslo, Norway
| | - Christopher D Whelan
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California, USA
- The Royal College of Surgeons in Ireland, Dublin 2, Ireland
| | - Beverly G Windham
- Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA
| | - Anderson M Winkler
- Department of Psychiatry, Yale University, New Haven, Connecticut, USA
- FMRIB Centre, University of Oxford, Oxford, UK
| | - Girma Woldehawariat
- Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA
| | - Christiane Wolf
- University of Wuerzburg, Department of Psychiatry, Psychosomatics and Psychotherapy, Wuerzburg, Germany
| | - Thomas Wolfers
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Bing Xu
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Lisa R Yanek
- GeneSTAR Research Center, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Jingyun Yang
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
| | - Alex Zijdenbos
- Biospective Inc, Montreal, Quebec, Canada, Montréal, Québec, Canada
| | - Marcel P Zwiers
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, The Netherlands
| | - Ingrid Agartz
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- Department of Research and Development, Diakonhjemmet Hospital, Oslo, Norway
- Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, Stockholm, Sweden
| | - Neelum T Aggarwal
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA
- Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
| | - Laura Almasy
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine Brownsville/Edinburg/San Antonio, Texas, USA
- Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
- Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
| | - David Ames
- National Ageing Research Institute, Royal Melbourne Hospital, Melbourne, Australia
- Academic Unit for Psychiatry of Old Age, University of Melbourne, Melbourne, Australia
| | - Philippe Amouyel
- Lille University, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk factors and molecular determinants of aging-related diseases, Lille, France
| | - Ole A Andreassen
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
| | - Sampath Arepalli
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Amelia A Assareh
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
| | - Sandra Barral
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA
| | - Mark E Bastin
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
| | - Diane M Becker
- GeneSTAR Research Center, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - James T Becker
- Departments of Psychiatry, Neurology, and Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - David A Bennett
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
| | - John Blangero
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine Brownsville/Edinburg/San Antonio, Texas, USA
| | - Hans van Bokhoven
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Dorret I Boomsma
- Biological Psychology, Neuroscience Campus Amsterdam, Vrije Universiteit University and Vrije Universiteit Medical Center, Amsterdam, the Netherlands
| | - Henry Brodaty
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
- Dementia Collaborative Research Centre - Assessment and Better Care, UNSW, Sydney, Australia
| | - Rachel M Brouwer
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Han G Brunner
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands
| | - Randy L Buckner
- Department of Psychiatry, Massachusetts General Hospital, Boston, Masschusetts, USA
- Department of Psychology, Center for Brain Science, Harvard University, Cambridge, Massachusetts, USA
| | - Jan K Buitelaar
- Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Karakter Child and Adolescent Psychiatry University Center, Nijmegen, the Netherlands
| | - Kazima B Bulayeva
- Department of Evolution and Genetics, Dagestan State University, Makhachkala, Dagestan, Russia
| | - Wiepke Cahn
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Vince D Calhoun
- The Mind Research Network and LBERI, Albuquerque, New Mexico, USA
- Department of ECE, University of New Mexico, Albuquerque, New Mexico, USA
| | - Dara M Cannon
- Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA
- Centre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland
| | | | - Christopher Chen
- Department of Pharmacology, National University of Singapore, Singapore
- Memory Aging and Cognition Centre (MACC), National University Health System, Singapore
| | - Ching-Yu Cheng
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore
- Academic Medicine Research Institute, Duke-NUS Graduate Medical School, Singapore
- Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - Sven Cichon
- Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland
- Institute of Human Genetics, University of Bonn, Bonn, Germany
- Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, Germany
| | - Mark R Cookson
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Aiden Corvin
- Psychosis Research Group, Department of Psychiatry and Trinity Translational Medicine Institute, Trinity College Dublin
| | - Benedicto Crespo-Facorro
- Department of Medicine and Psychiatry, University Hospital Marqués de Valdecilla, School of Medicine, University of Cantabria-IDIVAL, Santander, Spain
- CIBERSAM (Centro Investigación Biomédica en Red Salud Mental), Santander, Spain
| | - Joanne E Curran
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine Brownsville/Edinburg/San Antonio, Texas, USA
| | - Michael Czisch
- Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany
| | - Anders M Dale
- Center for Multimodal Imaging and Genetics, University of California, San Diego, California, USA
- Department of Neurosciences, University of California, San Diego, California, USA
- Department of Radiology, University of California, San Diego, California, USA
- Department of Psychiatry, University of California, San Diego, California, USA
- Department of Cognitive Science, University of California, San Diego, California, USA
| | - Gareth E Davies
- Avera Institute for Human Genetics, Sioux Falls, South Dakota, USA
- Program in Translational NeuroPsychiatric Genomics, Departments of Neurology and Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA
- Harvard Medical School, Boston, Massachusetts, USA
- Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, USA
| | - Eco J C De Geus
- Biological Psychology, Neuroscience Campus Amsterdam, Vrije Universiteit University and Vrije Universiteit Medical Center, Amsterdam, the Netherlands
| | - Philip L De Jager
- Harvard Medical School, Boston, Massachusetts, USA
- Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, USA
- Broad Institute, Cambridge, Massachusetts, USA
| | - Greig I de Zubicaray
- Faculty of Health and Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Brisbane, Australia
| | - Norman Delanty
- The Royal College of Surgeons in Ireland, Dublin 2, Ireland
- Neurology Division, Beaumont Hospital, Dublin, 9, Ireland
| | - Chantal Depondt
- Department of Neurology, Hopital Erasme, Universite Libre de Bruxelles, Brussels, Belgium
| | - Anita L DeStefano
- Framingham Heart Study, Framingham, Massachusetts, USA
- Dr. Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
| | - Allissa Dillman
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Srdjan Djurovic
- NORMENT - KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, Norway
- Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
| | - Gary Donohoe
- Cognitive Genetics and Cognitive Therapy Group, Neuroimaging, Cognition and Genomics Centre (NICOG) and NCBES Galway Neuroscience Centre, School of Psychology and Discipline of Biochemistry, National University of Ireland Galway, Galway, Ireland
- Neuropsychiatric Genetics Research Group, Department of Psychiatry and Trinity College Institute of Psychiatry, Trinity College Dublin, Dublin 8, Ireland
| | - Wayne C Drevets
- Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA
- Janssen Research and Development, LLC, Titusville, New Jersey, USA
| | - Ravi Duggirala
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine Brownsville/Edinburg/San Antonio, Texas, USA
| | - Thomas D Dyer
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine Brownsville/Edinburg/San Antonio, Texas, USA
| | - Susanne Erk
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin, Germany
| | - Thomas Espeseth
- NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
- NORMENT - KG Jebsen Centre, Department of Psychology, University of Oslo, Oslo, Norway
| | - Denis A Evans
- Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois, USA
| | - Iryna O Fedko
- Biological Psychology, Neuroscience Campus Amsterdam, Vrije Universiteit University and Vrije Universiteit Medical Center, Amsterdam, the Netherlands
| | - Guillén Fernández
- Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Luigi Ferrucci
- Intramural Research Program of the National Institute on Aging, Baltimore, Maryland, USA
| | - Simon E Fisher
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, the Netherlands
| | - Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA
- Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
- Department of Behavioral Sciences, Rush University Medical Center, Chicago, Illinois, USA
| | - Ian Ford
- Robertson Center for Biostatistics, University of Glasgow, Glasgow, UK
| | - Tatiana M Foroud
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Peter T Fox
- University of Texas Health Science Center, San Antonio, Texas, USA
| | - Clyde Francks
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
- Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, the Netherlands
| | - Masaki Fukunaga
- Division of Cerebral Integration, National Institute for Physiological Sciences, Aichi, Japan
| | - J Raphael Gibbs
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - David C Glahn
- Department of Psychiatry, Yale University, New Haven, Connecticut, USA
- Olin Neuropsychiatric Research Center, Hartford, Connecticut, USA
| | - Randy L Gollub
- Department of Psychiatry, Massachusetts General Hospital, Boston, Masschusetts, USA
- Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, North Carolina, USA
- Harvard Medical School, Boston, Massachusetts, USA
| | - Harald H H Göring
- South Texas Diabetes and Obesity Institute, University of Texas Rio Grande Valley School of Medicine Brownsville/Edinburg/San Antonio, Texas, USA
| | - Hans J Grabe
- Department of Psychiatry, University Medicine Greifswald, Greifswald, Germany
| | - Robert C Green
- Harvard Medical School, Boston, Massachusetts, USA
- Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA
| | - Oliver Gruber
- Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Germany
| | - Vilmundur Gudnason
- Icelandic Heart Association, Kopavogur, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - Sebastian Guelfi
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
| | - Narelle K Hansell
- QIMR Berghofer Medical Research Institute, Brisbane, Australia
- Queensland Brain Institute, University of Queensland, Brisbane, Australia
| | - John Hardy
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
| | - Catharina A Hartman
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Ryota Hashimoto
- Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan
- Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Osaka, Japan
| | - Katrin Hegenscheid
- Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin, Germany
| | - Stephanie Le Hellard
- NORMENT - KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, Norway
- Dr. Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
| | - Dena G Hernandez
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
- German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
| | - Dirk J Heslenfeld
- Department of Psychology, VU University Amsterdam, Amsterdam, the Netherlands
| | - Beng-Choon Ho
- Department of Psychiatry, University of Iowa, Iowa City, Iowa, USA
| | - Pieter J Hoekstra
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Wolfgang Hoffmann
- German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Greifswald, Germany
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Albert Hofman
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
| | - Florian Holsboer
- Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany
- HMNC Brain Health, Munich, Germany
| | - Georg Homuth
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany
| | - Norbert Hosten
- Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany
| | - Jouke-Jan Hottenga
- Biological Psychology, Neuroscience Campus Amsterdam, Vrije Universiteit University and Vrije Universiteit Medical Center, Amsterdam, the Netherlands
| | - Hilleke E Hulshoff Pol
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Masashi Ikeda
- Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan
| | - M Kamran Ikram
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
- Department of Pharmacology, National University of Singapore, Singapore
- Memory Aging and Cognition Centre (MACC), National University Health System, Singapore
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore
- Academic Medicine Research Institute, Duke-NUS Graduate Medical School, Singapore
| | - Clifford R Jack
- Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA
| | | | - Robert Johnson
- NICHD Brain and Tissue Bank for Developmental Disorders, University of Maryland Medical School, Baltimore, Maryland, USA
| | - Erik G Jönsson
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- FMRIB Centre, University of Oxford, Oxford, UK
| | - J Wouter Jukema
- Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
| | - René S Kahn
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Ryota Kanai
- School of Psychology, University of Sussex, Brighton, UK
- Institute of Cognitive Neuroscience, University College London, London, UK
- Department of Neuroinformatics, Araya Brain Imaging, Tokyo, Japan
| | | | - David S Knopman
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA
| | - Peter Kochunov
- Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA
| | - John B Kwok
- Neuroscience Research Australia, Sydney, Australia
- School of Medical Sciences, UNSW, Sydney, Australia
| | - Stephen M Lawrie
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
| | - Hervé Lemaître
- NSERM Unit 1000 ″Neuroimaging and Psychiatry″, University Paris Sud, University Paris Descartes, Paris, France
- Maison de Solenn, Adolescent Psychopathology and Medicine Department, APHP Hospital Cochin, Paris, France
| | - Xinmin Liu
- Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA
- Columbia University Medical Center, New York, New York, USA
| | - Dan L Longo
- Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA
| | - W T Longstreth
- Department of Neurology, University of Washington, Seattle, Washington, USA
- Department of Epidemiology, University of Washington, Seattle, Washington, USA
| | - Oscar L Lopez
- Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Simon Lovestone
- Department of Psychiatry, University of Oxford, Oxford, UK
- NIHR Dementia Biomedical Research Unit, King's College London, London, UK
| | - Oliver Martinez
- Imaging of Dementia and Aging (IDeA) Laboratory, Department of Neurology and Center for Neuroscience, University of California at Davis, Sacramento, California, USA
| | - Jean-Luc Martinot
- NSERM Unit 1000 ″Neuroimaging and Psychiatry″, University Paris Sud, University Paris Descartes, Paris, France
- Maison de Solenn, Adolescent Psychopathology and Medicine Department, APHP Hospital Cochin, Paris, France
| | - Venkata S Mattay
- Lieber Institute for Brain Development, Baltimore, Maryland, USA
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
- Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Colm McDonald
- Centre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland
| | - Andrew M McIntosh
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
| | - Katie L McMahon
- Centre for Advanced Imaging, University of Queensland, Brisbane, Australia
| | - Francis J McMahon
- Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, Bethesda, Maryland, USA
| | - Patrizia Mecocci
- Section of Gerontology and Geriatrics, Department of Medicine, University of Perugia, Perugia, Italy
| | - Ingrid Melle
- NORMENT - KG Jebsen Centre, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- NORMENT - KG Jebsen Centre, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
| | - Andreas Meyer-Lindenberg
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany
| | - Sebastian Mohnke
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin, Germany
| | | | - Derek W Morris
- Cognitive Genetics and Cognitive Therapy Group, Neuroimaging, Cognition and Genomics Centre (NICOG) and NCBES Galway Neuroscience Centre, School of Psychology and Discipline of Biochemistry, National University of Ireland Galway, Galway, Ireland
- Neuropsychiatric Genetics Research Group, Department of Psychiatry and Trinity College Institute of Psychiatry, Trinity College Dublin, Dublin 8, Ireland
| | - Thomas H Mosley
- Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA
| | - Thomas W Mühleisen
- Centre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland
- Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, Germany
| | - Bertram Müller-Myhsok
- Max Planck Institute of Psychiatry, Department of Translational Research in Psychiatry, Munich, Germany
- Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- University of Liverpool, Institute of Translational Medicine, Liverpool, UK
| | - Michael A Nalls
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Matthias Nauck
- Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany
- German Center for Cardiovascular Research (DZHK e.V.), partner site Greifswald, Germany
| | - Thomas E Nichols
- FMRIB Centre, University of Oxford, Oxford, UK
- Department of Statistics and Warwick Manufacturing Group, University of Warwick, Coventry, UK
| | - Wiro J Niessen
- Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands
- Department of Medical Informatics Erasmus MC, Rotterdam, the Netherlands
- Faculty of Applied Sciences, Delft University of Technology, Delft, the Netherlands
| | - Markus M Nöthen
- Institute of Human Genetics, University of Bonn, Bonn, Germany
- Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany
| | - Lars Nyberg
- Department of Integrative Medical Biology and Umeå center for Functional Brain Imaging, Umeå University, Umeå, Sweden
| | - Kazutaka Ohi
- Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan
| | - Rene L Olvera
- University of Texas Health Science Center, San Antonio, Texas, USA
| | - Roel A Ophoff
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
- Center for Neurobehavioral Genetics, University of California, Los Angeles, California, USA
| | - Massimo Pandolfo
- Department of Neurology, Hopital Erasme, Universite Libre de Bruxelles, Brussels, Belgium
| | - Tomas Paus
- Rotman Research Institute, University of Toronto, Toronto, Canada
- Departments of Psychology and Psychiatry, University of Toronto, Canada
- Child Mind Institute, New York, New York, USA
| | - Zdenka Pausova
- Hospital for Sick Children, University of Toronto, Toronto, Canada
- Department of Physiology, University of Toronto, Toronto, Canada
- Department of Nutritional Sciences, University of Toronto, Toronto, Canada
| | - Brenda W J H Penninx
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands
| | - G Bruce Pike
- Department of Radiology, University of Calgary, Calgary, Canada
- Department of Clinical Neuroscience, University of Calgary, Calgary, Canada
| | - Steven G Potkin
- Department of Psychiatry and Human Behavior, University of California-Irvine, Irvine, California, USA
| | - Bruce M Psaty
- Department of Epidemiology, University of Washington, Seattle, Washington, USA
- Department of Medicine, University of Washington, Seattle, Washington, USA
- Department of Health Services, University of Washington, Seattle, Washington, USA
- Group Health Research Institute, Group Health, Seattle, Washington, USA
| | - Simone Reppermund
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
- Department of Developmental Disability Neuropsychiatry, School of Psychiatry, UNSW Medicine, Australia
| | - Marcella Rietschel
- Central Institute of Mental Health, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany
| | - Joshua L Roffman
- Department of Psychiatry, Massachusetts General Hospital, Boston, Masschusetts, USA
| | - Nina Romanczuk-Seiferth
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin, Germany
| | - Jerome I Rotter
- Institute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute and Pediatrics at Harbor-UCLA Medical Center, Torrance, California, USA
| | - Mina Ryten
- Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK
- Department of Medical and Molecular Genetics, King's College London, London, UK
| | - Ralph L Sacco
- John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA
- Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida, USA
- Department of Epidemiology and Public Health Sciences, University of Miami, Miller School of Medicine, Miami, Florida, USA
- Evelyn F. McKnight Brain Institute, University of Miami, Miller School of Medicine, Miami, Florida, USA
| | - Perminder S Sachdev
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
- Neuropsychiatric Institute, Prince of Wales Hospital, Sydney, Australia
| | - Andrew J Saykin
- Center for Neuroimaging, Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indianapolis, Indiana, USA
- Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA
| | - Reinhold Schmidt
- Department of Neurology, Clinical Division of Neurogeriatrics, Medical University Graz, Austria, Graz, Austria
| | - Peter R Schofield
- Neuroscience Research Australia, Sydney, Australia
- School of Medical Sciences, UNSW, Sydney, Australia
| | | | - Andy Simmons
- Department of Neuroimaging, Institute of Psychiatry, King's College London, London, UK
- Biomedical Research Centre for Mental Health, King's College London, London, UK
- Biomedical Research Unit for Dementia, King's College London, London, UK
| | - Andrew Singleton
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Sanjay M Sisodiya
- UCL Institute of Neurology, London, United Kingdom and Epilepsy Society, Bucks, UK
| | - Colin Smith
- MRC Edinburgh Brain Bank, University of Edinburgh, Academic Department of Neuropathology, Centre for Clinical Brain Sciences, Edinburgh, UK
| | - Jordan W Smoller
- Department of Psychiatry, Massachusetts General Hospital, Boston, Masschusetts, USA
- Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA
- Harvard Medical School, Boston, Massachusetts, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Boston, Massachusetts, USA
| | - Hilkka Soininen
- Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland
- Neurocentre Neurology, Kuopio University Hospital, Finland
| | - Velandai Srikanth
- Department of Medicine, Peninsula Health and Monash University, Melbourne, Australia
| | - Vidar M Steen
- NORMENT - KG Jebsen Centre for Psychosis Research, Department of Clinical Science, University of Bergen, Norway
- Dr. Einar Martens Research Group for Biological Psychiatry, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
| | - David J Stott
- Institute of Cardiovascular and Medical Sciences, Faculty of Medicine, University of Glasgow, Glasgow, UK
| | - Jessika E Sussmann
- Division of Psychiatry, Royal Edinburgh Hospital, University of Edinburgh, Edinburgh, UK
| | - Anbupalam Thalamuthu
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
| | - Henning Tiemeier
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
- Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Arthur W Toga
- Laboratory of Neuro Imaging, Institute for Neuroimaging and Informatics, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA
| | - Bryan J Traynor
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Juan Troncoso
- Brain Resource Center, Johns Hopkins University, Baltimore, Maryland, USA
| | | | - Christophe Tzourio
- Institute for Neurodegenerative Disorders, UMR 5293, CEA, CNRS, Université de Bordeaux, France
| | - Andre G Uitterlinden
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
- Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands
| | - Maria C Valdés Hernández
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
| | | | - Aad Van der Lugt
- Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands
| | - Nic J A Van der Wee
- Department of Psychiatry and Leiden Institute for Brain and Cognition, Leiden University Medical Center, Leiden, The Netherlands
| | | | - Neeltje E M Van Haren
- Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht, the Netherlands
| | - Dennis Van T Ent
- Biological Psychology, Neuroscience Campus Amsterdam, Vrije Universiteit University and Vrije Universiteit Medical Center, Amsterdam, the Netherlands
| | - Marie-Jose Van Tol
- Neuroimaging Centre, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands
| | - Badri N Vardarajan
- Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA
| | - Dick J Veltman
- Department of Psychiatry, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands
| | - Meike W Vernooij
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
- Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands
| | - Henry Völzke
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
| | - Henrik Walter
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, CCM, Berlin, Germany
| | - Joanna M Wardlaw
- Brain Research Imaging Centre, University of Edinburgh, Edinburgh, UK
- Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
| | - Thomas H Wassink
- Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA
| | - Michael E Weale
- Department of Medical and Molecular Genetics, King's College London, London, UK
| | - Daniel R Weinberger
- Lieber Institute for Brain Development, Baltimore, Maryland, USA
- Departments of Psychiatry, Neurology, Neuroscience and the Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Michael W Weiner
- Center for Imaging of Neurodegenerative Disease, San Francisco VA Medical Center, University of California, San Francisco, California, USA
| | - Wei Wen
- Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
| | - Eric Westman
- Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
| | - Tonya White
- Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands
- Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Tien Y Wong
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore
- Department of Evolution and Genetics, Dagestan State University, Makhachkala, Dagestan, Russia
- Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - Clinton B Wright
- Department of Neurology, University of Miami, Miller School of Medicine, Miami, Florida, USA
- Department of Epidemiology and Public Health Sciences, University of Miami, Miller School of Medicine, Miami, Florida, USA
- Evelyn F. McKnight Brain Institute, University of Miami, Miller School of Medicine, Miami, Florida, USA
| | - H Ronald Zielke
- NICHD Brain and Tissue Bank for Developmental Disorders, University of Maryland Medical School, Baltimore, Maryland, USA
| | - Alan B Zonderman
- Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Ian J Deary
- Centre for Cognitive Ageing and Cognitive Epidemiology, Psychology, University of Edinburgh, Edinburgh, UK
| | - Charles DeCarli
- Imaging of Dementia and Aging (IDeA) Laboratory, Department of Neurology and Center for Neuroscience, University of California at Davis, Sacramento, California, USA
| | - Helena Schmidt
- Institute of Molecular Biology and Biochemistry, Medical University Graz, Graz, Austria
| | | | - Anton J M De Craen
- Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands
| | - Margaret J Wright
- Queensland Brain Institute, University of Queensland, Brisbane, Australia
- Centre for Advanced Imaging, University of Queensland, Brisbane, Australia
| | - Lenore J Launer
- Intramural Research Program, NIA, NIH, Bethesda, Maryland, USA
| | - Gunter Schumann
- MRC-SGDP Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Myriam Fornage
- Institute of Molecular Medicine and Human Genetics Center, University of Texas Health Science Center at Houston, Houston, Texas, USA
| | - Barbara Franke
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands
- Department of Psychiatry, Radboud University Medical Center, Nijmegen, the Netherlands
- Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands
| | - Stéphanie Debette
- Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
- Lieber Institute for Brain Development, Baltimore, Maryland, USA
- Department of Neurology, Bordeaux University Hospital, Bordeaux, France
| | - Sarah E Medland
- QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | - M Arfan Ikram
- Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
- Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands
- Department of Neurology, Erasmus MC, Rotterdam, the Netherlands
| | - Paul M Thompson
- Imaging Genetics Center, USC Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of University of Southern California, Los Angeles, California, USA
| |
Collapse
|
23
|
Boyle PA, Yu L, Fleischman DA, Leurgans S, Yang J, Wilson RS, Schneider JA, Arvanitakis Z, Arfanakis K, Bennett DA. White matter hyperintensities, incident mild cognitive impairment, and cognitive decline in old age. Ann Clin Transl Neurol 2016; 3:791-800. [PMID: 27752514 PMCID: PMC5048389 DOI: 10.1002/acn3.343] [Citation(s) in RCA: 79] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2016] [Revised: 06/27/2016] [Accepted: 08/02/2016] [Indexed: 11/17/2022] Open
Abstract
Objective Examine the association of white matter hyperintensities (WMH) with risk of incident mild cognitive impairment (MCI) and rate of decline in multiple cognitive systems in community‐based older persons. Methods Participants (n = 354) were older persons initially free of cognitive impairment from two ongoing longitudinal epidemiologic studies of aging. All underwent brain magnetic resonance imaging (MRI) for quantification of WMH and gray matter volumes and detailed annual clinical evaluations including 17 cognitive tests. Proportional hazards models were used to examine the relationship between WMH and incident MCI, and mixed‐effects models were used to examine the relationship between WMH and decline in global cognition and five specific cognitive systems. Results During up to about 6 years of follow‐up (mean = 4.1), 106 (30% of 354) persons developed MCI. In a proportional hazards model adjusted for age, gender, and education, WMH volume was associated with a substantially increased risk of MCI (P < 0.001). Thus, a person with a high WMH volume (90th percentile) was about 2.7 times more likely to develop MCI compared to a person with a low volume (10th percentile). WMH volume also was associated with an increased rate of decline in global cognition (P < 0.001), perceptual speed, working memory, episodic memory, and semantic memory. Associations persisted after adjustment for total gray matter volume, vascular risk factors, and vascular diseases. Interpretation WMH contribute to the development of MCI and are associated with progressive decline in multiple cognitive systems in old age.
Collapse
Affiliation(s)
- Patricia A Boyle
- Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois; Department of Behavioral Sciences Rush University Medical Center Chicago Illinois
| | - Lei Yu
- Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois; Department of Neurological Sciences Rush University Medical Center Chicago Illinois
| | - Debra A Fleischman
- Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois; Department of Behavioral Sciences Rush University Medical Center Chicago Illinois; Department of Neurological Sciences Rush University Medical Center Chicago Illinois
| | - Sue Leurgans
- Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois; Department of Neurological Sciences Rush University Medical Center Chicago Illinois
| | - Jingyun Yang
- Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois; Department of Neurological Sciences Rush University Medical Center Chicago Illinois
| | - Robert S Wilson
- Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois; Department of Behavioral Sciences Rush University Medical Center Chicago Illinois; Department of Neurological Sciences Rush University Medical Center Chicago Illinois
| | - Julie A Schneider
- Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois; Department of Neurological Sciences Rush University Medical Center Chicago Illinois; Department of Pathology Rush University Medical Center Chicago Illinois
| | - Zoe Arvanitakis
- Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois; Department of Neurological Sciences Rush University Medical Center Chicago Illinois
| | - Konstantinos Arfanakis
- Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois; Department of Biomedical Engineering Illinois Institute of Technology Chicago Illinois; Department of Diagnostic Radiology and Nuclear Medicine Rush University Medical Center Chicago Illinois
| | - David A Bennett
- Rush Alzheimer's Disease Center Rush University Medical Center Chicago Illinois; Department of Neurological Sciences Rush University Medical Center Chicago Illinois
| |
Collapse
|
24
|
Gabrieli JD, Fleischman DA, Keane MM, Reminger SL, Morrell F. Double Dissociation Between Memory Systems Underlying Explicit and Implicit Memory in the Human Brain. Psychol Sci 2016. [DOI: 10.1111/j.1467-9280.1995.tb00310.x] [Citation(s) in RCA: 216] [Impact Index Per Article: 27.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
Amnesic patients have impaired explicit memory that is evident in poor recall and recognition of words, yet can have intact implicit memory for words as measured by repetition priming, the enhanced efficiency for reprocessing those words The dissociation between explicit and implicit memory for words is a fundamental characteristic of normal cognition that could reflect two different functional architectures of the human brain two separate processing systems or two levels of operation of a single system with implicit memory less demanding of that system We present a patient who has a lesion in the right occipital lobe and who showed intact explicit and impaired implicit memory for words The deficit was specific to visual priming The double dissociation between explicit and implicit visual memory for words indicates that separate processing systems mediate these two forms of memory, and that a memory system in right occipital cortex mediates implicit visual memory for words
Collapse
Affiliation(s)
- John D.E. Gabrieli
- Department of Neurological Sciences, Rush-Presbyterian-St Luke's Medical Center
- Memory Disorders Research Center, Boston University School of Medicine and Boston Department of Veterans Affairs
- Department of Psychology, Stanford University
| | - Debra A. Fleischman
- Department of Neurological Sciences, Rush-Presbyterian-St Luke's Medical Center
| | - Margaret M. Keane
- Memory Disorders Research Center, Boston University School of Medicine and Boston Department of Veterans Affairs
| | - Sheryl L. Reminger
- Department of Neurological Sciences, Rush-Presbyterian-St Luke's Medical Center
| | - Frank Morrell
- Department of Neurological Sciences, Rush-Presbyterian-St Luke's Medical Center
| |
Collapse
|
25
|
Felsky D, De Jager PL, Schneider JA, Arfanakis K, Fleischman DA, Arvanitakis Z, Honer WG, Pouget JG, Mizrahi R, Pollock BG, Kennedy JL, Bennett DA, Voineskos AN. Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant. J Cereb Blood Flow Metab 2016; 36:819-30. [PMID: 26762507 PMCID: PMC4821029 DOI: 10.1177/0271678x15626719] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/06/2015] [Revised: 11/12/2015] [Accepted: 11/16/2015] [Indexed: 02/06/2023]
Abstract
The translocator protein, a microglial-expressed marker of neuroinflammation, has been implicated in Alzheimer's disease, which is characterized by alterations in vascular and inflammatory states. ATSPOvariant, rs6971, determines binding affinity of exogenous radioligandsin vivo; however, the effect of these altered binding characteristics on inflammatory and cerebrovascular biomarkers has not been assessed. In 2345 living subjects (Alzheimer's Disease Neuroimaging Initiative, n = 1330) and postmortem brain samples (Religious Orders Study and Memory and Aging Project, n = 1015), we analyzed effects of rs6971 on white matter hyperintensisites, cerebral infarcts, circulating inflammatory biomarkers, amyloid angiopathy, and microglial activation. We found that rs6971 does not alter translocator protein in a way that impacts cerebrovascular and inflammatory states known to be affected in dementia.
Collapse
Affiliation(s)
- Daniel Felsky
- Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada Institute of Medical Science, University of Toronto, King's College Circle, Toronto, ON, Canada
| | - Philip L De Jager
- Program in Translational NeuroPsychiatric Genomics, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA
| | - Julie A Schneider
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA
| | - Konstantinos Arfanakis
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA Department of Biomedical Engineering, Illinois Institute of Technology, IL, USA
| | - Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Zoe Arvanitakis
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - William G Honer
- BC Mental Health and Addictions Research Institute, University of British Columbia, Vancouver, BC, Canada
| | - Jennie G Pouget
- Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada Institute of Medical Science, University of Toronto, King's College Circle, Toronto, ON, Canada
| | - Romina Mizrahi
- Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada Institute of Medical Science, University of Toronto, King's College Circle, Toronto, ON, Canada
| | - Bruce G Pollock
- Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada Institute of Medical Science, University of Toronto, King's College Circle, Toronto, ON, Canada
| | - James L Kennedy
- Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada Institute of Medical Science, University of Toronto, King's College Circle, Toronto, ON, Canada
| | - David A Bennett
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Aristotle N Voineskos
- Campbell Family Mental Health Institute, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada Institute of Medical Science, University of Toronto, King's College Circle, Toronto, ON, Canada
| |
Collapse
|
26
|
Lim ASP, Fleischman DA, Dawe RJ, Yu L, Arfanakis K, Buchman AS, Bennett DA. Regional Neocortical Gray Matter Structure and Sleep Fragmentation in Older Adults. Sleep 2016; 39:227-35. [PMID: 26350471 DOI: 10.5665/sleep.5354] [Citation(s) in RCA: 65] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2015] [Accepted: 07/24/2015] [Indexed: 12/31/2022] Open
Abstract
STUDY OBJECTIVES To test the hypothesis that greater sleep fragmentation is associated with regionally decreased cortical gray matter volume in older community-dwelling adults without cognitive impairment. METHODS We studied 141 community-dwelling older adults (median age 82.9; 73% female) without cognitive impairment or stroke, and not using sedative/ hypnotic medications, participating in the Rush Memory and Aging Project. We quantified sleep fragmentation from 7 d of actigraphy using the metric kRA and related this to total cortical gray matter volume, and regional gray matter volume in 34 cortical regions quantified by automated segmentation of magnetic resonance imaging data. We determined statistical significance and accounted for multiple comparisons by empirically estimating the false discovery rate by permutation. RESULTS Lower total cortical gray matter volume was associated with higher sleep fragmentation (coefficient +0.23, standard error [SE] 0.11, P = 0.037). Lower gray matter volumes in four cortical regions were accompanied by higher sleep fragmentation with a false discovery rate < 0.05: the left (coefficient +0.36, SE 0.10, P = 2.7 × 10(-4)) and right (coefficient +0.31, SE 0.10, P = 4.0 × 10(-3)) lateral orbitofrontal cortices, and the adjacent left (coefficient +0.31, SE 0.10, 5.4 × 10(-4)) and right (coefficient +0.39, SE 0.10, P = 1.2 × 10(-4)) inferior frontal gyri pars orbitalis. These associations were unchanged after accounting for age, sex, education, depression, cognitive function, and a number of medical comorbidities. CONCLUSIONS Lower cortical gray matter volume in the lateral orbitofrontal cortex and inferior frontal gyrus pars orbitalis is associated with greater sleep fragmentation in older community-dwelling adults. Further work is needed to clarify whether this is a consequence of or contributor to sleep fragmentation. COMMENTARY A commentary on this article appears in this issue on page 15.
Collapse
Affiliation(s)
- Andrew S P Lim
- Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
| | - Debra A Fleischman
- Rush Alzheimer Disease Center and Department of Neurological Sciences, Rush University, Chicago, IL
| | - Robert J Dawe
- Rush Alzheimer Disease Center and Department of Neurological Sciences, Rush University, Chicago, IL.,Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, IL
| | - Lei Yu
- Rush Alzheimer Disease Center and Department of Neurological Sciences, Rush University, Chicago, IL
| | - Konstantinos Arfanakis
- Rush Alzheimer Disease Center and Department of Neurological Sciences, Rush University, Chicago, IL.,Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, IL.,Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL
| | - Aron S Buchman
- Rush Alzheimer Disease Center and Department of Neurological Sciences, Rush University, Chicago, IL
| | - David A Bennett
- Rush Alzheimer Disease Center and Department of Neurological Sciences, Rush University, Chicago, IL
| |
Collapse
|
27
|
Lee SJ, Adams HH, Chouraki V, Satizabal CL, Yang Q, Li S, Debette SA, Yanek LR, DeCarli C, Hofer E, Yu L, Smith AV, Amin N, Seshadri S, Launer LJ, Tzourio C, Mazoyer B, Chauhan G, Jager P, Arfanakis K, Fleischman DA, Bennett DA, Ikram MA, Duijn CM. O4‐05‐02: Genome‐wide association study of lobar brain volumes. Alzheimers Dement 2015. [DOI: 10.1016/j.jalz.2015.07.370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
| | | | | | | | - Qiong Yang
- Boston University School of Public HealthBostonMAUSA
| | - Shuo Li
- Boston University School of Public HealthBostonMAUSA
| | | | | | | | - Edith Hofer
- Institut für Medizinische InformatikStatistik und DokumentationGrazAustria
| | - Lei Yu
- Rush University Medical CenterChicagoILUSA
| | | | - Najaf Amin
- Erasmus Medical CenterRotterdamNetherlands
| | - Sudha Seshadri
- Boston University School of MedicineBostonMAUSA
- The Framingham Heart StudyFraminghamMAUSA
| | | | | | | | | | - Philip Jager
- Brigham and Women's HospitalBostonMAUSA
- Broad InstituteCambridgeMAUSA
| | | | | | | | | | | | | |
Collapse
|
28
|
Arvanitakis Z, Fleischman DA, Arfanakis K, Leurgans SE, Barnes LL, Bennett DA. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment. Brain Struct Funct 2015; 221:2135-46. [PMID: 25833685 PMCID: PMC4592368 DOI: 10.1007/s00429-015-1034-7] [Citation(s) in RCA: 69] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2014] [Accepted: 03/19/2015] [Indexed: 01/18/2023]
Abstract
Both presence of white matter hyperintensities (WMH) and smaller total gray matter volume on brain magnetic resonance imaging (MRI) are common findings in old age, and contribute to impaired cognition. We tested whether total WMH volume and gray matter volume had independent associations with cognition in community-dwelling individuals without dementia or mild cognitive impairment (MCI). We used data from participants of the Rush Memory and Aging Project. Brain MRI was available in 209 subjects without dementia or MCI (mean age 80; education = 15 years; 74 % women). WMH and gray matter were automatically segmented, and the total WMH and gray matter volumes were measured. Both MRI-derived measures were normalized by the intracranial volume. Cognitive data included composite measures of five different cognitive domains, based on 19 individual tests. Linear regression analyses, adjusted for age, sex, and education, were used to examine the relationship of logarithmically-transformed total WMH volume and of total gray matter volume to cognition. Larger total WMH volumes were associated with lower levels of perceptual speed (p < 0.001), but not with episodic memory, semantic memory, working memory, or visuospatial abilities (all p > 0.10). Smaller total gray matter volumes were associated with lower levels of perceptual speed (p = 0.013) and episodic memory (p = 0.001), but not with the other three cognitive domains (all p > 0.14). Larger total WMH volume was correlated with smaller total gray matter volume (p < 0.001). In a model with both MRI-derived measures included, the relation of WMH to perceptual speed remained significant (p < 0.001), while gray matter volumes were no longer related (p = 0.14). This study of older community-dwelling individuals without overt cognitive impairment suggests that the association of larger total WMH volume with lower perceptual speed is independent of total gray matter volume. These results help elucidate the pathological processes leading to lower cognitive function in aging.
Collapse
Affiliation(s)
- Zoe Arvanitakis
- Rush Alzheimer's Disease Center, Rush University Medical Center, 600 S. Paulina Ave, Suite 1020, Chicago, IL, 60612, USA. .,Department of Neurological Sciences, Rush University Medical Center, Chicago, USA.
| | - Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, 600 S. Paulina Ave, Suite 1020, Chicago, IL, 60612, USA.,Department of Neurological Sciences, Rush University Medical Center, Chicago, USA.,Department of Behavioral Sciences, Rush University Medical Center, Chicago, USA
| | - Konstantinos Arfanakis
- Rush Alzheimer's Disease Center, Rush University Medical Center, 600 S. Paulina Ave, Suite 1020, Chicago, IL, 60612, USA.,Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, USA.,Department of Biomedical Engineering, Illinois Institute of Technology, Rush University Medical Center, Chicago, USA
| | - Sue E Leurgans
- Rush Alzheimer's Disease Center, Rush University Medical Center, 600 S. Paulina Ave, Suite 1020, Chicago, IL, 60612, USA.,Department of Neurological Sciences, Rush University Medical Center, Chicago, USA
| | - Lisa L Barnes
- Rush Alzheimer's Disease Center, Rush University Medical Center, 600 S. Paulina Ave, Suite 1020, Chicago, IL, 60612, USA.,Department of Neurological Sciences, Rush University Medical Center, Chicago, USA.,Department of Behavioral Sciences, Rush University Medical Center, Chicago, USA
| | - David A Bennett
- Rush Alzheimer's Disease Center, Rush University Medical Center, 600 S. Paulina Ave, Suite 1020, Chicago, IL, 60612, USA.,Department of Neurological Sciences, Rush University Medical Center, Chicago, USA
| |
Collapse
|
29
|
Fleischman DA, Yang J, Arfanakis K, Arvanitakis Z, Leurgans SE, Turner AD, Barnes LL, Bennett DA, Buchman AS. Physical activity, motor function, and white matter hyperintensity burden in healthy older adults. Neurology 2015; 84:1294-300. [PMID: 25762710 DOI: 10.1212/wnl.0000000000001417] [Citation(s) in RCA: 59] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To test the hypothesis that physical activity modifies the association between white matter hyperintensity (WMH) burden and motor function in healthy older persons without dementia. METHODS Total daily activity (exercise and nonexercise physical activity) was measured for up to 11 days with actigraphy (Actical; Philips Respironics, Bend, OR) in 167 older adults without dementia participating in the Rush Memory and Aging Project. Eleven motor performances were summarized into a previously described global motor score. WMH volume was expressed as percent of intracranial volume. Linear regression models, adjusted for age, education, and sex, were performed with total WMH volume as the predictor and global motor score as the outcome. Terms for total daily physical activity and its interaction with WMH volume were then added to the model. RESULTS Higher WMH burden was associated with lower motor function (p = 0.006), and total daily activity was positively associated with motor function (p = 0.002). Total daily activity modified the association between WMH and motor function (p = 0.007). WMH burden was not associated with motor function in persons with high activity (90th percentile). By contrast, higher WMH burden remained associated with lower motor function in persons with average (50th percentile; estimate = -0.304, slope = -0.133) and low (10th percentile; estimate = -1.793, slope = -0.241) activity. CONCLUSIONS Higher levels of physical activity may reduce the effect of WMH burden on motor function in healthy older adults.
Collapse
Affiliation(s)
- Debra A Fleischman
- From the Rush Alzheimer's Disease Center (D.A.F., J.Y., K.A., Z.A., S.E.L., A.D.T., L.L.B., D.A.B., A.S.B.) and Departments of Neurological Sciences (D.A.F., J.Y., Z.A., S.E.L., L.L.B., D.A.B., A.S.B.), Behavioral Sciences (D.A.F., L.L.B.), Diagnostic Radiology and Nuclear Medicine (K.A.), and Preventive Medicine (S.E.L.), Rush University Medical Center, Chicago; and Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago.
| | - Jingyun Yang
- From the Rush Alzheimer's Disease Center (D.A.F., J.Y., K.A., Z.A., S.E.L., A.D.T., L.L.B., D.A.B., A.S.B.) and Departments of Neurological Sciences (D.A.F., J.Y., Z.A., S.E.L., L.L.B., D.A.B., A.S.B.), Behavioral Sciences (D.A.F., L.L.B.), Diagnostic Radiology and Nuclear Medicine (K.A.), and Preventive Medicine (S.E.L.), Rush University Medical Center, Chicago; and Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago
| | - Konstantinos Arfanakis
- From the Rush Alzheimer's Disease Center (D.A.F., J.Y., K.A., Z.A., S.E.L., A.D.T., L.L.B., D.A.B., A.S.B.) and Departments of Neurological Sciences (D.A.F., J.Y., Z.A., S.E.L., L.L.B., D.A.B., A.S.B.), Behavioral Sciences (D.A.F., L.L.B.), Diagnostic Radiology and Nuclear Medicine (K.A.), and Preventive Medicine (S.E.L.), Rush University Medical Center, Chicago; and Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago
| | - Zoe Arvanitakis
- From the Rush Alzheimer's Disease Center (D.A.F., J.Y., K.A., Z.A., S.E.L., A.D.T., L.L.B., D.A.B., A.S.B.) and Departments of Neurological Sciences (D.A.F., J.Y., Z.A., S.E.L., L.L.B., D.A.B., A.S.B.), Behavioral Sciences (D.A.F., L.L.B.), Diagnostic Radiology and Nuclear Medicine (K.A.), and Preventive Medicine (S.E.L.), Rush University Medical Center, Chicago; and Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago
| | - Sue E Leurgans
- From the Rush Alzheimer's Disease Center (D.A.F., J.Y., K.A., Z.A., S.E.L., A.D.T., L.L.B., D.A.B., A.S.B.) and Departments of Neurological Sciences (D.A.F., J.Y., Z.A., S.E.L., L.L.B., D.A.B., A.S.B.), Behavioral Sciences (D.A.F., L.L.B.), Diagnostic Radiology and Nuclear Medicine (K.A.), and Preventive Medicine (S.E.L.), Rush University Medical Center, Chicago; and Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago
| | - Arlener D Turner
- From the Rush Alzheimer's Disease Center (D.A.F., J.Y., K.A., Z.A., S.E.L., A.D.T., L.L.B., D.A.B., A.S.B.) and Departments of Neurological Sciences (D.A.F., J.Y., Z.A., S.E.L., L.L.B., D.A.B., A.S.B.), Behavioral Sciences (D.A.F., L.L.B.), Diagnostic Radiology and Nuclear Medicine (K.A.), and Preventive Medicine (S.E.L.), Rush University Medical Center, Chicago; and Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago
| | - Lisa L Barnes
- From the Rush Alzheimer's Disease Center (D.A.F., J.Y., K.A., Z.A., S.E.L., A.D.T., L.L.B., D.A.B., A.S.B.) and Departments of Neurological Sciences (D.A.F., J.Y., Z.A., S.E.L., L.L.B., D.A.B., A.S.B.), Behavioral Sciences (D.A.F., L.L.B.), Diagnostic Radiology and Nuclear Medicine (K.A.), and Preventive Medicine (S.E.L.), Rush University Medical Center, Chicago; and Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago
| | - David A Bennett
- From the Rush Alzheimer's Disease Center (D.A.F., J.Y., K.A., Z.A., S.E.L., A.D.T., L.L.B., D.A.B., A.S.B.) and Departments of Neurological Sciences (D.A.F., J.Y., Z.A., S.E.L., L.L.B., D.A.B., A.S.B.), Behavioral Sciences (D.A.F., L.L.B.), Diagnostic Radiology and Nuclear Medicine (K.A.), and Preventive Medicine (S.E.L.), Rush University Medical Center, Chicago; and Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago
| | - Aron S Buchman
- From the Rush Alzheimer's Disease Center (D.A.F., J.Y., K.A., Z.A., S.E.L., A.D.T., L.L.B., D.A.B., A.S.B.) and Departments of Neurological Sciences (D.A.F., J.Y., Z.A., S.E.L., L.L.B., D.A.B., A.S.B.), Behavioral Sciences (D.A.F., L.L.B.), Diagnostic Radiology and Nuclear Medicine (K.A.), and Preventive Medicine (S.E.L.), Rush University Medical Center, Chicago; and Biomedical Engineering (K.A.), Illinois Institute of Technology, Chicago
| |
Collapse
|
30
|
Shah RC, Matthews DC, Andrews RD, Capuano AW, Fleischman DA, VanderLugt JT, Colca JR. An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease. Curr Alzheimer Res 2015; 11:564-73. [PMID: 24931567 PMCID: PMC4153084 DOI: 10.2174/1567205011666140616113406] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2014] [Revised: 05/18/2014] [Accepted: 05/19/2014] [Indexed: 12/02/2022]
Abstract
Alzheimer’s disease (AD) is associated with insulin resistance and specific regional declines in cerebral metabolism. The effects of a novel mTOT modulating insulin sensitizer (MSDC-0160) were explored in non-diabetic patients with mild AD to determine whether treatment would impact glucose metabolism measured by FDG-PET in regions that decline in AD. MSDC-0160 (150 mg once daily; N=16) compared to placebo (N=13) for 12 weeks did not result in a significant difference in glucose metabolism in pre-defined regions when referenced to the pons or whole brain. However, glucose metabolism referenced to cerebellum was maintained in MSDC-0160 treated participants while it significantly declined for placebo patients in anterior and posterior cingulate, and parietal, lateral temporal, medial temporal cortices. Voxel-based analyses showed additional differences in FDG-PET related to MSDC-0160 treatment. These exploratory results suggest central effects of MSDC-0160 and provide a basis for further investigation of mTOT modulating insulin sensitizers in AD patients.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Jerry R Colca
- Metabolic Solutions Development Company, Kalamazoo, MI, USA.
| |
Collapse
|
31
|
Han SD, Boyle PA, Yu L, Fleischman DA, Arfanakis K, Leurgans S, Bennett DA. Financial literacy is associated with medial brain region functional connectivity in old age. Arch Gerontol Geriatr 2014; 59:429-38. [PMID: 24893911 PMCID: PMC4130771 DOI: 10.1016/j.archger.2014.05.001] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2013] [Revised: 05/08/2014] [Accepted: 05/10/2014] [Indexed: 10/25/2022]
Abstract
Financial literacy refers to the ability to access and utilize financial information in ways that promote better outcomes. In old age, financial literacy has been associated with a wide range of positive characteristics; however, the neural correlates remain unclear. Recent work has suggested greater co-activity between anterior-posterior medial brain regions is associated with better brain functioning. We hypothesized financial literacy would be associated with this pattern. We assessed whole-brain functional connectivity to a posterior cingulate cortex (PCC) seed region of interest (ROI) in 138 participants of the Rush Memory and Aging Project. Results revealed financial literacy was associated with greater functional connectivity between the PCC and three regions: the right ventromedial prefrontal cortex (vmPFC), the left postcentral gyrus, and the right precuneus. Results also revealed financial literacy was associated negatively with functional connectivity between the PCC and left caudate. Post hoc analyses showed the PCC-vmPFC relationship accounted for the most variance in a regression model adjusted for all four significant functional connectivity relationships, demographic factors, and global cognition. These findings provide information on the neural mechanisms associated with financial literacy in old age.
Collapse
Affiliation(s)
- S Duke Han
- Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA; Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA; Mental Health Care Group, VA Long Beach Healthcare System, Long Beach, CA, USA.
| | - Patricia A Boyle
- Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA; Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA
| | - Lei Yu
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Debra A Fleischman
- Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA; Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - Konstantinos Arfanakis
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA; Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA; Department of Radiology, Rush University Medical Center, Chicago, IL, USA
| | - Sue Leurgans
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| | - David A Bennett
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
| |
Collapse
|
32
|
Han SD, Boyle PA, Yu L, Fleischman DA, Arfanakis K, Bennett DA. Ventromedial PFC, parahippocampal, and cerebellar connectivity are associated with temporal discounting in old age. Exp Gerontol 2013; 48:1489-98. [PMID: 24135750 DOI: 10.1016/j.exger.2013.10.003] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2013] [Revised: 09/17/2013] [Accepted: 10/07/2013] [Indexed: 12/01/2022]
Abstract
Temporal discounting occurs when a greater delayed reward is forsaken for a smaller immediate reward, and has been associated with a number of financial and health care outcomes important for older adults. Using resting-state fMRI and seed regions of interest in the left and right fronto-insular (FI) cortices, we explored the neurobiological substrate of temporal discounting in 123 non-demented older adults from the Rush Memory and Aging Project. For the left FI cortex, temporal discounting was positively associated with functional connectivity to the right ventromedial prefrontal cortex and middle temporal regions, and negatively associated with parahippocampal and right cerebellar regions. For the right FI cortex, temporal discounting was negatively associated with functional connectivity to a right cerebellar region. Connectivity maps of both left and right seed regions of interest overlapped in the right cerebellum. Results support the notion of different brain functional connectivity patterns associated with the dynamic range of temporal discounting in old age.
Collapse
Affiliation(s)
- S Duke Han
- Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL 60612, United States; Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612, United States; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, United States; Mental Health Care Group, VA Long Beach Healthcare System, Long Beach, CA 90822, United States.
| | | | | | | | | | | |
Collapse
|
33
|
Arfanakis K, Fleischman DA, Grisot G, Barth CM, Varentsova A, Morris MC, Barnes LL, Bennett DA. Systemic inflammation in non-demented elderly human subjects: brain microstructure and cognition. PLoS One 2013; 8:e73107. [PMID: 23991174 PMCID: PMC3753267 DOI: 10.1371/journal.pone.0073107] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2013] [Accepted: 07/24/2013] [Indexed: 11/23/2022] Open
Abstract
The purpose of this study was to test the hypothesis that higher levels of systemic inflammation in a community sample of non-demented subjects older than seventy years of age are associated with reduced diffusion anisotropy in brain white matter and lower cognition. Ninety-five older persons without dementia underwent detailed clinical and cognitive evaluation and magnetic resonance imaging, including diffusion tensor imaging. Systemic inflammation was assessed with a composite measure of commonly used circulating inflammatory markers (C-reactive protein and tumor necrosis factor-alpha). Tract-based spatial statistics analyses demonstrated that diffusion anisotropy in the body and isthmus of the corpus callosum was negatively correlated with the composite measure of systemic inflammation, controlling for demographic, clinical and radiologic factors. Visuospatial ability was negatively correlated with systemic inflammation, and diffusion anisotropy in the body and isthmus of the corpus callosum was shown to mediate this association. The findings of the present study suggest that higher levels of systemic inflammation may be associated with lower microstructural integrity in the corpus callosum of non-demented elderly individuals, and this may partially explain the finding of reduced higher-order visual cognition in aging.
Collapse
Affiliation(s)
- Konstantinos Arfanakis
- Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois, USA.
| | | | | | | | | | | | | | | |
Collapse
|
34
|
Fleischman DA, Leurgans S, Arfanakis K, Arvanitakis Z, Barnes LL, Boyle PA, Han SD, Bennett DA. Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognition. Brain Struct Funct 2013; 219:2029-49. [PMID: 23955313 DOI: 10.1007/s00429-013-0622-7] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2013] [Accepted: 07/29/2013] [Indexed: 10/26/2022]
Abstract
A deeper understanding of brain macrostructure and its associations with cognition in persons who are considered cognitively healthy is critical to the early detection of persons at risk of developing dementia. Few studies have examined the associations of all three gray-matter macrostructural brain indices (volume, thickness, surface area) with age and cognition, in the same persons who are over the age of 65 and do not have cognitive impairment. We performed automated morphometric reconstruction of total gray matter, cortical gray matter, subcortical gray matter and 84 individual regions in 186 persons (60 % over the age of 80) without cognitive impairment. Morphometric measures were scaled and expressed as difference per decade of age and an adjusted score was created to identify those regions in which there was greater atrophy per decade of age compared to cortical or subcortical brain averages. The results showed that there is substantial total volume loss and cortical thinning in cognitively healthy older persons. Thinning was more widespread than volume loss, but volume loss, particularly in temporoparietal and hippocampal regions, was more strongly associated with cognition.
Collapse
Affiliation(s)
- Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Armour Academic Center Offices, 600 S. Paulina Suite 1038, 1653 W. Congress Parkway, Chicago, IL, 60612, USA,
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Han SD, Buchman AS, Arfanakis K, Fleischman DA, Bennett DA. Functional connectivity networks associated with chronic musculoskeletal pain in old age. Int J Geriatr Psychiatry 2013; 28:858-67. [PMID: 23124844 PMCID: PMC3594549 DOI: 10.1002/gps.3898] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/13/2012] [Accepted: 10/10/2012] [Indexed: 11/11/2022]
Abstract
OBJECTIVE Musculoskeletal disorders are common and often lead to chronic pain in older adults. Because the efficacy of interventions varies with the duration of pain, the identification of early biomarkers for chronic pain would have important public health consequences. Imaging of functional connectivity differences between brain regions might identify some of the earliest functional consequences of a disease process. We tested the hypothesis that chronic musculoskeletal pain in older persons is associated with changes in functional brain connectivity. METHOD We used resting-state functional magnetic resonance imaging and a spherical seed-based region of interest approach to assess functional connectivity of brain regions on a sample of 128 (64 who reported chronic musculoskeletal pain and 64 demographically matched, pain free) nondemented older adults from the Memory and Aging Project, a clinical-pathological cohort study of aging and dementia. RESULTS Older adults with chronic pain showed greater functional connectivity between the posterior cingulate and left insula, left superior temporal gyrus, and left cerebellum. CONCLUSION Chronic musculoskeletal pain is associated with a specific pattern of functional connectivity between brain regions among older adults.
Collapse
Affiliation(s)
- S. Duke Han
- Department of Behavioral Sciences, Rush University Medical Center,Rush Alzheimer’s Disease Center, Rush University Medical Center,Mental Health Care Group, VA Long Beach Healthcare System
| | - Aron S. Buchman
- Rush Alzheimer’s Disease Center, Rush University Medical Center,Department of Neurological Sciences, Rush University Medical Center
| | - Konstantinos Arfanakis
- Department of Biomedical Engineering, Illinois Institute of Technology,Rush Alzheimer’s Disease Center, Rush University Medical Center,Department of Radiology, Rush University Medical Center
| | - Debra A. Fleischman
- Department of Behavioral Sciences, Rush University Medical Center,Rush Alzheimer’s Disease Center, Rush University Medical Center,Department of Neurological Sciences, Rush University Medical Center
| | - David A. Bennett
- Rush Alzheimer’s Disease Center, Rush University Medical Center,Department of Neurological Sciences, Rush University Medical Center
| |
Collapse
|
36
|
Fleischman DA, Yu L, Arfanakis K, Han SD, Barnes LL, Arvanitakis Z, Boyle PA, Bennett DA. Faster cognitive decline in the years prior to MR imaging is associated with smaller hippocampal volumes in cognitively healthy older persons. Front Aging Neurosci 2013; 5:21. [PMID: 23760360 PMCID: PMC3672675 DOI: 10.3389/fnagi.2013.00021] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2013] [Accepted: 05/16/2013] [Indexed: 11/13/2022] Open
Abstract
Early identification of persons at risk for cognitive decline in aging is critical to optimizing treatment to delay or avoid a clinical diagnosis of mild cognitive impairment (MCI) or dementia due to Alzheimer's disease (AD). To accomplish early identification, it is essential that trajectories of cognitive change be characterized and associations with established biomarkers of MCI and AD be examined during the phase in which older persons are considered cognitively healthy. Here we examined the association of rate of cognitive decline in the years leading up to structural magnetic resonance imaging with an established biomarker, hippocampal volume. The sample comprised 211 participants of the Rush Memory and Aging Project who had an average of 5.5 years of cognitive data prior to structural scanning. Results showed that there was significant variability in the trajectories of cognitive change prior to imaging and that faster cognitive decline was associated with smaller hippocampal volumes. Domain-specific analyses suggested that this association was primarily driven by decline in working memory. The results emphasize the importance of closely examining cognitive change and its association with brain structure during the years in which older persons are considered cognitively healthy.
Collapse
Affiliation(s)
- Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center Chicago, IL, USA ; Department of Neurological Sciences, Rush University Medical Center Chicago, IL, USA ; Department of Behavioral Sciences, Rush University Medical Center Chicago, IL, USA
| | | | | | | | | | | | | | | |
Collapse
|
37
|
Arvanitakis Z, Brey RL, Rand JH, Schneider JA, Leurgans SE, Yu L, Buchman AS, Arfanakis K, Fleischman DA, Boyle PA, Bennett DA, Levine SR. Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology 2012; 40:73-84. [PMID: 23095514 PMCID: PMC3638838 DOI: 10.1159/000342761] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2012] [Accepted: 08/15/2012] [Indexed: 11/19/2022] Open
Abstract
The overall goal of the Antiphospholipid Antibodies, Brain Infarcts, and Cognitive and Motor Decline in Aging study is to test the hypothesis that antiphospholipid antibodies (aPL) are associated with an increased risk of pathologically proven brain infarcts and are related to cognitive and motor decline in aging. Putative biologic mechanisms underlying the association of aPL with infarcts and the relation of aPL with clinical outcomes of cognitive and motor impairment, including vascular and other processes, will be examined. The design of this longitudinal, clinical-pathologic study involves quantifying four aPL assays, and relating these to brain infarcts, and to cognitive and motor decline. Vascular mechanisms assessed using antemortem magnetic resonance neuroimaging and postmortem neuropathology, as well as nonvascular mechanisms of inflammation and blood-brain barrier permeability alterations will be examined as plausible mediators of the relation of aPL to cognitive and motor impairment. We will take advantage of antemortem biological specimens (longitudinally collected sera and plasma from which aPL, annexins, C-reactive protein, and matrix metalloproteinases will be quantified), and clinical, neuroimaging, and postmortem neuropathologic data from about 800 elderly, community-dwelling women and men who have agreed to brain autopsy at the time of death, participating in one of two ongoing studies of aging: the Religious Orders Study and the Memory and Aging Project.
Collapse
Affiliation(s)
- Zoe Arvanitakis
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL
| | - Robin L. Brey
- Dept of Neurology, University of Texas Health Science Center at San Antonio, TX
| | - Jacob H. Rand
- Dept of Pathology, Montefiore Medical Center, Bronx, NY
| | - Julie A. Schneider
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL
| | - Sue E. Leurgans
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL
| | - Lei Yu
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL
| | - Aron S. Buchman
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL
| | - Konstantinos Arfanakis
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL
- Dept of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL
| | - Debra A. Fleischman
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL
| | - Patricia A. Boyle
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL
| | - David A. Bennett
- Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL
| | - Steven R. Levine
- Dept of Neurology, State University of New York Downstate Medical Center, Brooklyn, NY
| |
Collapse
|
38
|
Han SD, Boyle PA, Arfanakis K, Fleischman DA, Yu L, Edmonds EC, Bennett DA. Neural intrinsic connectivity networks associated with risk aversion in old age. Behav Brain Res 2011; 227:233-40. [PMID: 22044475 DOI: 10.1016/j.bbr.2011.10.026] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2011] [Revised: 09/29/2011] [Accepted: 10/17/2011] [Indexed: 10/15/2022]
Abstract
Risk aversion is associated with several important real world outcomes. Although the neurobiological correlates of risk aversion have been studied in young persons, little is known of the neurobiological correlates of risk aversion among older persons. Resting-state functional MRI data were collected on 134 non-demented participants of the Rush Memory and Aging Project, a community-based cohort study of aging. Risk aversion was measured using a series of standard questions in which participants were asked to choose between a certain monetary payment ($15) versus a gamble in which they could gain more than $15 or gain nothing, with potential gains varied across questions. Participants determined to be "high" (n=27) and "low" (n=27) in risk aversion were grouped accordingly. Using a spherical seed region of interest in the anterior cingulate cortex, voxel-wise functional connectivity network similarities were observed in bilateral frontal, anterior and posterior cingulate, insula, basal ganglia, temporal, parietal, and thalamic regions. Differences in functional connectivity were observed such that those low in risk aversion had greater connectivity to clusters in the superior, middle, and medial frontal regions, as well as cerebellar, parietal, occipital, and inferior temporal regions. Those high in risk aversion had greater connectivity to clusters in the inferior and orbital frontal, parahippocampal, and insula regions, as well as thalamic, parietal, precentral gyrus, postcentral gyrus, and middle temporal regions. Similarities and differences in functional connectivity patterns may reflect the historical recruitment of specific brain regions as a network in the active processing of risk in older adults.
Collapse
Affiliation(s)
- S Duke Han
- Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL 60612, USA.
| | | | | | | | | | | | | |
Collapse
|
39
|
Fleischman DA, Arfanakis K, Kelly JF, Rajendran N, Buchman AS, Morris MC, Barnes LL, Bennett DA. Regional brain cortical thinning and systemic inflammation in older persons without dementia. J Am Geriatr Soc 2010; 58:1823-5. [PMID: 20863359 DOI: 10.1111/j.1532-5415.2010.03049.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
40
|
Buchman AS, Boyle PA, Wilson RS, Fleischman DA, Leurgans S, Bennett DA. Association between late-life social activity and motor decline in older adults. ACTA ACUST UNITED AC 2009; 169:1139-46. [PMID: 19546415 DOI: 10.1001/archinternmed.2009.135] [Citation(s) in RCA: 160] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
BACKGROUND Loss of motor function is a common consequence of aging, but little is known about the factors that predict idiopathic motor decline. Our objective was to test the hypothesis that late-life social activity is related to the rate of change in motor function in old age. METHODS Longitudinal cohort study with a mean follow-up of 4.9 years with 906 persons without stroke, Parkinson disease, or dementia participating in the Rush Memory and Aging Project. At baseline, participants rated the frequency of their current participation in common social activities from which a summary measure of social activity was derived. The main outcome measure was annual change in a composite measure of global motor function, based on 9 measures of muscle strength and 9 motor performances. RESULTS Mean (SD) social activity score at baseline was 2.6 (0.58), with higher scores indicating more frequent participation in social activities. In a generalized estimating equation model, controlling for age, sex, and education, global motor function declined by approximately 0.05 U/y (estimate, 0.016; 95% confidence interval [CI], -0.057 to 0.041 [P = .02]). Each 1-point decrease in social activity was associated with approximately a 33% more rapid rate of decline in motor function (estimate, 0.016; 95% CI, 0.003 to 0.029 [P = .02]). The effect of each 1-point decrease in the social activity score at baseline on the rate of change in global motor function was the same as being approximately 5 years older at baseline (age estimate, -0.003; 95% CI, -0.004 to -0.002 [P<.001]). Furthermore, this amount of motor decline per year was associated with a more than 40% increased risk of death (hazard ratio, 1.44; 95% CI, 1.30 to 1.60) and a 65% increased risk of incident Katz disability (hazard ratio, 1.65; 95% CI, 1.48 to 1.83). The association of social activity with the rate of global motor decline did not vary along demographic lines and was unchanged (estimate, 0.025; 95% CI, 0.005 to 0.045 [P = .01]) after controlling for potential confounders including late-life physical and cognitive activity, disability, global cognition depressive symptoms, body composition, and chronic medical conditions. CONCLUSION Less frequent participation in social activities is associated with a more rapid rate of motor function decline in old age.
Collapse
Affiliation(s)
- Aron S Buchman
- Departments of Neurological Sciences, Rush Alzheimer's Disease Center, Rush University Medical Center, Armour Academic Facility, Chicago, IL 60612, USA.
| | | | | | | | | | | |
Collapse
|
41
|
Fleischman DA, Bienias JL, Bennett DA. Repetition priming and change in functional ability in older persons without dementia. Neuropsychology 2009; 23:98-104. [PMID: 19210037 DOI: 10.1037/a0013994] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
Adverse consequences such as institutionalization and death are associated with compromised activities of daily living in aging, yet there is little known about risk factors for the development and progression of functional disability. Using generalized linear models, the authors examined the association between the ability to benefit from repetition and rate of change in functional ability in 160 nondemented elders participating in the Religious Orders Study. Three single-word repetition priming tasks were administered that varied in the degree to which visual-perceptual or conceptual processing was invoked. Decline in functional ability was less rapid, during follow-up of up to 10 years, in persons with better baseline priming performance on a task known to draw on both visual-perceptual and conceptual processing (word-stem completion). By contrast, change in functional ability was not associated with priming on tasks that are known to draw primarily on either visual-perceptual (threshold word-identification) or conceptual (category exemplar production) processing. The results are discussed in terms of a common biological substrate in the inferotemporal neocortex, supporting efficient processing of meaningful visual-perceptual experience and proficient performance of activities of daily living.
Collapse
Affiliation(s)
- Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612, USA.
| | | | | |
Collapse
|
42
|
Fleischman DA, Buchman AS, Bienias JL, Bennett DA. Visuoperceptual repetition priming and progression of parkinsonian signs in aging. Neurobiol Aging 2009; 30:441-9. [PMID: 17709154 PMCID: PMC2666281 DOI: 10.1016/j.neurobiolaging.2007.07.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2007] [Revised: 06/19/2007] [Accepted: 07/07/2007] [Indexed: 10/22/2022]
Abstract
Parkinsonian signs in older persons are associated with numerous adverse health outcomes, however there is limited information about factors which predict progression of these signs. Using generalized linear models, we examined the association between efficiency in visuoperceptual and conceptual processing, measured by repetition priming, and rate of change in parkinsonian signs in a large sample of older persons without cognitive impairment or Parkinson's disease. Subjects with better visuoperceptual priming, measured by threshold word-identification and word-stem completion, at study baseline, progressed more slowly during follow-up of up to 11 years. Conceptual priming was not associated with change in parkinsonian signs. The findings demonstrate that individual differences in visuoperceptual processing efficiency, measured by repetition priming, occur in older persons without cognitive impairment and predict important changes in motor function. Reduced visuoperceptual priming in aging may be an early signal of vulnerability in a corticostrial circuit that contributes to sensorimotor integration.
Collapse
Affiliation(s)
- Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
| | | | | | | |
Collapse
|
43
|
Abstract
Two decades of research examining repetition priming in aging and Alzheimer's disease (AD) has yielded a large body of contradictory findings due to differences between studies in participant and task characteristics. Recent research that has employed methodological advances indicates that this form of implicit memory is preserved in healthy aging. When a priming deficit does occur in studies of aging, it is likely a very early signal of neurological disease. Future directions for research in this area include linking priming ability to known risk factors for development of AD, integrating priming measures into clinical neuropsychological assessment batteries, and implementing programs of cognitive retraining that enhance memory using stimulus repetition techniques.
Collapse
Affiliation(s)
- Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612, USA.
| |
Collapse
|
44
|
Buchman AS, Wilson RS, Boyle PA, Tang Y, Fleischman DA, Bennett DA. Physical Activity and Leg Strength Predict Decline in Mobility Performance in Older Persons. J Am Geriatr Soc 2007; 55:1618-23. [PMID: 17697103 DOI: 10.1111/j.1532-5415.2007.01359.x] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
OBJECTIVES To assess the extent to which physical activity and leg strength are associated with change in mobility in older persons. DESIGN Prospective, observational cohort study. SETTING Retirement communities across the Chicago metropolitan area participating in the Rush Memory and Aging Project. PARTICIPANTS Eight hundred eighty-six ambulatory older persons without dementia. MEASUREMENT Rate of change in mobility. RESULTS In a linear mixed-effects model that controlled for age, sex, education, and a term for baseline physical activity, a higher level of physical activity was associated with a slower rate of mobility decline (estimate=0.006, standard error (SE)=0.003, P=.03); each additional hour of physical activity at baseline was associated with an approximately 3% decrease in the rate of mobility decline. In a similar model, a higher level of baseline leg strength was associated with a slower rate of mobility decline (estimate=0.031, SE=0.132, P=.02); each additional unit of leg strength at baseline was associated with an approximately 20% decrease in the rate of mobility decline. In a final model, which included terms for physical activity and leg strength together, both were associated with decline in mobility. Furthermore, both remained associated with mobility even after controlling for body composition, balance, pulmonary function, cognition, history of joint pain, cardiovascular diseases and risk factors, and medications. CONCLUSION Physical activity and leg strength are relatively independent predictors of mobility decline in older persons. Although physical activity may improve strength, the beneficial effect of physical activity on mobility is likely to involve other pathways.
Collapse
Affiliation(s)
- Aron S Buchman
- Alzheimer's Disease Center, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA.
| | | | | | | | | | | |
Collapse
|
45
|
Abstract
Little is known about the association between parkinsonian signs and functional disability. The authors examined the associations between four parkinsonian signs (gait, rigidity, bradykinesia, tremor) and the ability to perform physical and instrumental activities of daily living, in a large cohort of older Rush Memory and Aging Project participants who were free of dementia, Parkinson's disease, and antipsychotic drug use. In a series of logistic regression equations that controlled for age, sex, education, depressive symptoms, cognitive ability, chronic medical conditions, and psychotropic drug use, higher levels of parkinsonian signs were associated with higher levels of disability in performing both physical and instrumental activities of daily living.
Collapse
Affiliation(s)
- Debra A Fleischman
- Rush Alzheimer's Disease Center and Departments of Neurological Sciences and Behavioral Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA.
| | | | | | | | | |
Collapse
|
46
|
Fleischman DA, Gabrieli JDE, Wilson RS, Moro TT, Bennett DA. Repetition priming and recognition memory in younger and older persons: temporal stability and performance. Neuropsychology 2006; 19:750-9. [PMID: 16351350 DOI: 10.1037/0894-4105.19.6.750] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
The dissociation between intact priming and reduced explicit memory in aging has been called into question on the basis of limited information that suggests that priming measures are less reliable than explicit memory measures. No aging study to date, however, has offered a comprehensive examination of the reliability of these measures. Age-related performance and test-retest stability coefficients for multiple priming and explicit memory tasks were compared. Age effects were found on some tasks but not others, and stability was not related to task performance. Stability was similar for implicit versus explicit task instructions, younger versus older persons, and studied versus unstudied items. Results indicate that dissociations between priming and explicit memory performances cannot be accounted for by differential reliability of the measures.
Collapse
|
47
|
Fleischman DA, Wilson RS, Bienias JL, Bennett DA. Parkinsonian signs and cognitive function in old age. J Int Neuropsychol Soc 2005; 11:591-7. [PMID: 16212686 DOI: 10.1017/s1355617705050708] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/11/2004] [Revised: 04/16/2005] [Accepted: 04/16/2005] [Indexed: 11/07/2022]
Abstract
Studies have shown that parkinsonian signs are related to cognitive function in aging. What remains unclear is whether this association is stronger for some cognitive domains than it is for others, and precisely how much variability in global and specific cognitive functions is explained by the motor signs. We examined the associations between four parkinsonian signs (gait, rigidity, bradykinesia, tremor) and five cognitive domains (episodic memory, semantic memory, working memory, perceptual speed, visuospatial ability) in a large cohort of older persons who were free of Parkinson's disease and dementia and were participating in the Rush Memory and Aging Project. In a series of regression equations that controlled for age, sex, and education, higher levels of three signs (gait, rigidity, and bradykinesia) were related to lower levels of cognitive function, but they accounted for less than 5% of the variance in most measures. The results did not change when the presence of depressive symptoms, diabetes, and hypertension were added to the models. The cross-sectional association between parkinsonian signs and cognitive function did not vary substantially across specific cognitive domains or specific cognitive tests. The results suggest that parkinsonian signs have a modest, but statistically reliable, association with level of cognitive function in old age.
Collapse
Affiliation(s)
- Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois 60612, USA.
| | | | | | | |
Collapse
|
48
|
Abstract
Explicit memory failure is the defining cognitive feature of Alzheimer's disease and relates to the hallmark neuropathological features (plaques and tangles) of this illness. However, a pattern of preserved and impaired implicit memory has been found in Alzheimer's disease patients that may be explained by the association between the processing demands of certain implicit tests and the level of regional Alzheimer's disease neuropathology. In this study, we tested the hypothesis that these neuropathological features are related to implicit memory--measured by repetition priming--in a test that emphasized conceptual (or meaning-based) cognitive processing, and that the pathological changes are not related to implicit memory in a repetition priming test that emphasized perceptual (or sensory-based) cognitive processing. Subjects were older nuns, priests and brothers participating in the Religious Orders Study who agreed to annual neurological and neuropsychological evaluation for Alzheimer's disease and common neurological conditions of ageing, and brain autopsy at time of death. Explicit memory was measured by seven tests of episodic recall and recognition and converted to a previously established summary measure. Implicit memory was measured by four repetition priming tests. One test, category exemplar priming, emphasized conceptual, or meaning-based cognitive processing. A second test, word-identification priming, emphasized perceptual, or sensory-based cognitive processing. Two additional priming tests, picture-naming and word-stem completion, invoke both conceptual and perceptual processes. Neuritic and diffuse plaques, and neurofibrillary tangles identified by Bielschowsky silver stain, were quantified from five regions separately (frontal, parietal, temporal, entorhinal cortex and the hippocampus) and converted to a previously established summary measure. In linear regression analyses--controlling for age, sex and education--higher levels of Alzheimer's disease neuropathology were related to lower levels of explicit memory proximate to death. Higher levels of neuropathology were also related to lower levels of priming on the category-exemplar test, but were not related to levels of priming on the word-identification, picture-naming, or word-stem completion tests. The results suggest that hallmark indices of Alzheimer's disease neuropathology are associated with performance on priming tests to the extent that conceptual, but not perceptual, processing resources are required.
Collapse
Affiliation(s)
- Debra A Fleischman
- Rush Alzheimer's Disease Center, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.
| | | | | | | | | | | |
Collapse
|
49
|
Abstract
Decline in explicit memory with advancing age is a common finding, but it is unclear whether implicit memory (repetition priming) declines or remains stable. Meta-analyses of studies that examined differences between extreme groups (young-old), typically at a single point in time and on a single test, suggest that a mild reduction in priming occurs with advancing age. The authors examined explicit memory and priming, on multiple tests over 4 annual data-collection waves, in a large group of older persons without dementia at baseline. Explicit memory declined significantly, but priming remained stable. Findings indicate that explicit memory and priming are dissociable on the basis of age-related change and that mildly reduced priming is not an inevitable consequence of growing older.
Collapse
Affiliation(s)
- Debra A Fleischman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL 60612, USA.
| | | | | | | | | |
Collapse
|
50
|
Stebbins GT, Fleischman DA, Bangen KA, Turner DA, Bennett DA, Gabrieli JD. P2-231 Voxel-based morphometry contributions to the diagnosis of mild cognitive impairment. Neurobiol Aging 2004. [DOI: 10.1016/s0197-4580(04)80977-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|